|
OMIM |
Link |
Information gain |
01 |
|
RA
|
[NCBI]
|
0.00254755
|
|
|
RDPA
|
[NCBI]
|
0.00160726
|
|
|
iminoglycinuria
|
[NCBI]
|
0.00141508
|
|
|
SLE
|
[NCBI]
|
0.00134435
|
|
|
LI5
|
[NCBI]
|
0.00124481
|
|
|
EFMR
|
[NCBI]
|
0.000972075
|
|
|
UFS
|
[NCBI]
|
0.000888078
|
|
|
beta-aminoisobutyric acid, urinary excretion of
|
[NCBI]
|
0.000820387
|
|
|
MRT5
|
[NCBI]
|
0.000802798
|
|
|
RP22
|
[NCBI]
|
0.000802798
|
|
|
MRT10
|
[NCBI]
|
0.000802798
|
|
|
DFNB35
|
[NCBI]
|
0.000802798
|
|
|
DFNB63
|
[NCBI]
|
0.000802798
|
|
|
DFNB17
|
[NCBI]
|
0.000802798
|
|
|
MCPH2
|
[NCBI]
|
0.000802798
|
|
|
SLSN3
|
[NCBI]
|
0.000802798
|
|
|
MSSD
|
[NCBI]
|
0.000802798
|
|
|
MRT8
|
[NCBI]
|
0.000802798
|
|
|
DFNB27
|
[NCBI]
|
0.000802798
|
|
|
salivary substance, clostridium botulinum type
|
[NCBI]
|
0.000802798
|
|
|
MRT11
|
[NCBI]
|
0.000802798
|
|
|
muscular dystrophy, congenital, 1b
|
[NCBI]
|
0.000802798
|
|
|
MRT9
|
[NCBI]
|
0.000802798
|
|
|
RP25
|
[NCBI]
|
0.000802798
|
|
|
camptobrachydactyly
|
[NCBI]
|
0.000802798
|
|
|
MRT7
|
[NCBI]
|
0.000802798
|
|
|
DFNB39
|
[NCBI]
|
0.000802798
|
|
|
xanthomatosis, susceptibility to
|
[NCBI]
|
0.000802798
|
|
|
deafness, congenital neurosensory, autosomal recessive 38
|
[NCBI]
|
0.000802798
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
0.000737717
|
|
|
AMCN
|
[NCBI]
|
0.000672847
|
|
|
microcephalic osteodysplastic primordial dwarfism, type i
|
[NCBI]
|
0.000672847
|
|
|
MYP2
|
[NCBI]
|
0.000543202
|
|
|
stomatocytosis ii
|
[NCBI]
|
0.00054047
|
|
|
MRT12
|
[NCBI]
|
0.00054047
|
|
|
PDB4
|
[NCBI]
|
0.00054047
|
|
|
NNCI
|
[NCBI]
|
0.00054047
|
|
|
saccharopinuria
|
[NCBI]
|
0.00054047
|
|
|
DFNB13
|
[NCBI]
|
0.00054047
|
|
|
SCAR5
|
[NCBI]
|
0.00054047
|
|
|
myasthenia, familial infantile, 1
|
[NCBI]
|
0.00054047
|
|
|
epilepsy, partial, with variable foci
|
[NCBI]
|
0.00054047
|
|
|
SCAR3
|
[NCBI]
|
0.00054047
|
|
|
diarrhea 3, secretory sodium, congenital
|
[NCBI]
|
0.00054047
|
|
|
EGF
|
[NCBI]
|
0.000498866
|
|
|
IGAD1
|
[NCBI]
|
0.000494091
|
|
|
USH1E
|
[NCBI]
|
0.000443255
|
|
|
MHAC
|
[NCBI]
|
0.000443255
|
|
|
thyroid hormonogenesis, genetic defect in, 4
|
[NCBI]
|
0.000443255
|
|
|
CHDS8
|
[NCBI]
|
0.000443255
|
|
|
DFNB5
|
[NCBI]
|
0.000443255
|
|
|
b-cell malignancy, low-grade
|
[NCBI]
|
0.000443255
|
|
|
alzheimer disease 11
|
[NCBI]
|
0.000443255
|
|
|
pentosuria
|
[NCBI]
|
0.000443255
|
|
|
bruck syndrome 1
|
[NCBI]
|
0.000443255
|
|
|
anodontia of permanent dentition
|
[NCBI]
|
0.000443255
|
|
|
SCAR6
|
[NCBI]
|
0.000443255
|
|
|
CRC
|
[NCBI]
|
0.000435606
|
|
|
HFE
|
[NCBI]
|
0.000430475
|
|
|
MDD
|
[NCBI]
|
0.000423904
|
|
|
JBTS1
|
[NCBI]
|
0.000415014
|
|
|
cholestasis-lymphedema syndrome
|
[NCBI]
|
0.000381137
|
|
|
MYP3
|
[NCBI]
|
0.000381137
|
|
|
peeling skin syndrome
|
[NCBI]
|
0.000381137
|
|
|
VDEGS
|
[NCBI]
|
0.000381137
|
|
|
CMT2B2
|
[NCBI]
|
0.000381137
|
|
|
noonan syndrome 2
|
[NCBI]
|
0.000381137
|
|
|
VEGF
|
[NCBI]
|
0.000370443
|
|
|
migraine with or without aura, susceptibility to, 1
|
[NCBI]
|
0.000339917
|
|
|
cerebral palsy, ataxic, autosomal recessive
|
[NCBI]
|
0.000335688
|
|
|
NAD
|
[NCBI]
|
0.000335688
|
|
|
cerebellar ataxia and hypogonadotropic hypogonadism
|
[NCBI]
|
0.000335688
|
|
|
chorioretinal dystrophy, spinocerebellar ataxia, and hypogonadotropic hypogonadism
|
[NCBI]
|
0.000335688
|
|
|
USH2B
|
[NCBI]
|
0.000335688
|
|
|
IBD3
|
[NCBI]
|
0.000335688
|
|
|
HBFQTL2
|
[NCBI]
|
0.000327161
|
|
|
myeloproliferative syndrome, transient
|
[NCBI]
|
0.000327161
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
0.000303446
|
|
|
CCA1
|
[NCBI]
|
0.000300057
|
|
|
MKS2
|
[NCBI]
|
0.000300057
|
|
|
RNANC
|
[NCBI]
|
0.000300057
|
|
|
STHAG4
|
[NCBI]
|
0.000300057
|
|
|
dysgnathia complex
|
[NCBI]
|
0.000300057
|
|
|
CNC2
|
[NCBI]
|
0.000300057
|
|
|
erythrocytosis, familial, 2
|
[NCBI]
|
0.000282197
|
|
|
TNF
|
[NCBI]
|
0.000276579
|
|
|
SPS
|
[NCBI]
|
0.000271737
|
|
|
maxillonasal dysplasia, binder type
|
[NCBI]
|
0.000270913
|
|
|
DBQD
|
[NCBI]
|
0.000270913
|
|
|
neuropathy, hereditary motor and sensory, russe type
|
[NCBI]
|
0.000270913
|
|
|
BMND3
|
[NCBI]
|
0.000270913
|
|
|
gonadal dysgenesis, xx type, with deafness
|
[NCBI]
|
0.000270913
|
|
|
AD
|
[NCBI]
|
0.000265869
|
|
|
FMF
|
[NCBI]
|
0.000257407
|
|
|
MG
|
[NCBI]
|
0.000250839
|
|
|
MTHFR
|
[NCBI]
|
0.000247428
|
|
|
alzheimer disease 5
|
[NCBI]
|
0.00024638
|
|
|
alzheimer disease 8
|
[NCBI]
|
0.00024638
|
|
|
BBS
|
[NCBI]
|
0.000244142
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
0.000231599
|
|
|
NGFB
|
[NCBI]
|
0.000230024
|
|
|
IBD2
|
[NCBI]
|
0.000225295
|
|
|
ADFN
|
[NCBI]
|
0.000225295
|
|
|
LDLR
|
[NCBI]
|
0.000224805
|
|
|
gaucher disease, type iiic
|
[NCBI]
|
0.000219062
|
|
|
CF
|
[NCBI]
|
0.000214125
|
|
|
SHFM1
|
[NCBI]
|
0.0002116
|
|
|
factor v deficiency
|
[NCBI]
|
0.000210557
|
|
|
stiff skin syndrome
|
[NCBI]
|
0.000206886
|
|
|
TOC
|
[NCBI]
|
0.000206886
|
|
|
PEE1
|
[NCBI]
|
0.000204271
|
|
|
NPHP2
|
[NCBI]
|
0.000204143
|
|
|
APRT
|
[NCBI]
|
0.000203514
|
|
|
NPY
|
[NCBI]
|
0.000196274
|
|
|
PI
|
[NCBI]
|
0.00019555
|
|
|
KLK3
|
[NCBI]
|
0.000194405
|
|
|
PRL
|
[NCBI]
|
0.000194357
|
|
|
ACG1A
|
[NCBI]
|
0.000190615
|
|
|
PTH
|
[NCBI]
|
0.000189495
|
|
|
PCNA
|
[NCBI]
|
0.000187216
|
|
|
APC
|
[NCBI]
|
0.000186465
|
|
|
AT
|
[NCBI]
|
0.000185417
|
|
|
HBB
|
[NCBI]
|
0.000185377
|
|
|
EAOH
|
[NCBI]
|
0.000184236
|
|
|
HHC1
|
[NCBI]
|
0.000179431
|
|
|
SLSN1
|
[NCBI]
|
0.000171994
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
0.000171614
|
|
|
porphyria variegata
|
[NCBI]
|
0.00017155
|
|
|
WRN
|
[NCBI]
|
0.000170821
|
|
|
WFS2
|
[NCBI]
|
0.000156785
|
|
|
ARH
|
[NCBI]
|
0.000156496
|
|
|
ACADM
|
[NCBI]
|
0.000155476
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
0.000153943
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
0.000151361
|
|
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
0.000151187
|
|
|
CCK
|
[NCBI]
|
0.000150231
|
|
|
LGMD2I
|
[NCBI]
|
0.000149855
|
|
|
mitochondrial dna depletion syndrome, hepatocerebral form
|
[NCBI]
|
0.000149855
|
|
|
langer mesomelic dysplasia
|
[NCBI]
|
0.000149855
|
|
|
NPC1
|
[NCBI]
|
0.000148312
|
|
|
EGFR
|
[NCBI]
|
0.000145978
|
|
|
PWS
|
[NCBI]
|
0.000145684
|
|
|
SMA1
|
[NCBI]
|
0.00014433
|
|
|
gilbert syndrome
|
[NCBI]
|
0.000143788
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000143269
|
|
|
CEACAM5
|
[NCBI]
|
0.000142172
|
|
|
F5F8D
|
[NCBI]
|
0.00014104
|
|
|
giant platelet syndrome
|
[NCBI]
|
0.000141013
|
|
|
glaucoma-related pigment dispersion syndrome
|
[NCBI]
|
0.000140404
|
|
|
alopecia areata 1
|
[NCBI]
|
0.000140404
|
|
|
LI1
|
[NCBI]
|
0.000137291
|
|
|
CFTR
|
[NCBI]
|
0.000137197
|
|
|
VIP
|
[NCBI]
|
0.000135796
|
|
|
ABL
|
[NCBI]
|
0.00013472
|
|
|
gaucher disease, type i
|
[NCBI]
|
0.000133236
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
0.000133048
|
|
|
hydatidiform mole
|
[NCBI]
|
0.000133048
|
|
|
AMDM
|
[NCBI]
|
0.000131184
|
|
|
PRNP
|
[NCBI]
|
0.00012952
|
|
|
ACHE
|
[NCBI]
|
0.000128417
|
|
|
GJB2
|
[NCBI]
|
0.000127518
|
|
|
cystinuria
|
[NCBI]
|
0.0001251
|
|
|
CRH
|
[NCBI]
|
0.000123816
|
|
|
complement component 2 deficiency
|
[NCBI]
|
0.000123671
|
|
|
polycystic kidneys
|
[NCBI]
|
0.000123446
|
|
|
MRT3
|
[NCBI]
|
0.000118932
|
|
|
LCA4
|
[NCBI]
|
0.000118932
|
|
|
hypotonia-cystinuria syndrome
|
[NCBI]
|
0.000118932
|
|
|
MCPH5
|
[NCBI]
|
0.00011564
|
|
|
CMT4C
|
[NCBI]
|
0.00011564
|
|
|
APL
|
[NCBI]
|
0.000115628
|
|
|
mismatch repair cancer syndrome
|
[NCBI]
|
0.000115628
|
|
|
SHFM3
|
[NCBI]
|
0.0001131
|
|
|
IGAN1
|
[NCBI]
|
0.0001131
|
|
|
CDAN2
|
[NCBI]
|
0.0001131
|
|
|
ARSA
|
[NCBI]
|
0.000112637
|
|
|
PHA1
|
[NCBI]
|
0.000109296
|
|
|
TGD
|
[NCBI]
|
0.000108388
|
|
|
HGF
|
[NCBI]
|
0.000108331
|
|
|
AFP
|
[NCBI]
|
0.000105261
|
|
|
BLM
|
[NCBI]
|
0.000104279
|
|
|
plasminogen deficiency, type i
|
[NCBI]
|
0.000103639
|
|
|
von willebrand disease, recessive form
|
[NCBI]
|
0.000103639
|
|
|
mitochondrial dna depletion syndrome, myopathic form
|
[NCBI]
|
0.000103639
|
|
|
acheiropody
|
[NCBI]
|
0.000103639
|
|
|
HHF4
|
[NCBI]
|
0.000102045
|
|
|
LI3
|
[NCBI]
|
0.000102045
|
|
|
CLN7
|
[NCBI]
|
0.000102045
|
|
|
APOE
|
[NCBI]
|
0.000101757
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
9.98136e-05
|
|
|
SMN1
|
[NCBI]
|
9.97525e-05
|
|
|
HPS
|
[NCBI]
|
9.92597e-05
|
|
|
LCA1
|
[NCBI]
|
9.88698e-05
|
|
|
adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency
|
[NCBI]
|
9.85403e-05
|
|
|
small cell cancer of the lung
|
[NCBI]
|
9.81835e-05
|
|
|
thrombocytopenia-absent radius syndrome
|
[NCBI]
|
9.81835e-05
|
|
|
GFAP
|
[NCBI]
|
9.70702e-05
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
9.59948e-05
|
|
|
ACHM2
|
[NCBI]
|
9.39062e-05
|
|
|
complement component 7 deficiency
|
[NCBI]
|
9.39062e-05
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
9.34156e-05
|
|
|
ACH
|
[NCBI]
|
9.30513e-05
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
9.15103e-05
|
|
|
FTD
|
[NCBI]
|
9.10238e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type ii
|
[NCBI]
|
9.05795e-05
|
|
|
STL3
|
[NCBI]
|
9.05795e-05
|
|
|
waardenburg-shah syndrome
|
[NCBI]
|
8.96637e-05
|
|
|
GAN1
|
[NCBI]
|
8.96637e-05
|
|
|
complement factor h deficiency
|
[NCBI]
|
8.96637e-05
|
|
|
UGT1A1
|
[NCBI]
|
8.96506e-05
|
|
|
BIRC1
|
[NCBI]
|
8.88501e-05
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
8.81066e-05
|
|
|
phenylketonuria
|
[NCBI]
|
8.8015e-05
|
|
|
GBA
|
[NCBI]
|
8.64386e-05
|
|
|
PFIC1
|
[NCBI]
|
8.57561e-05
|
|
|
PARK6
|
[NCBI]
|
8.57561e-05
|
|
|
NBIA1
|
[NCBI]
|
8.57561e-05
|
|
|
CCR5
|
[NCBI]
|
8.50457e-05
|
|
|
EPO
|
[NCBI]
|
8.43228e-05
|
|
|
SLC5A5
|
[NCBI]
|
8.41183e-05
|
|
|
hyperlipoproteinemia, type i
|
[NCBI]
|
8.21382e-05
|
|
|
refsum disease
|
[NCBI]
|
8.21382e-05
|
|
|
RSMD1
|
[NCBI]
|
8.21382e-05
|
|
|
alkaptonuria
|
[NCBI]
|
8.21382e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2b1
|
[NCBI]
|
8.18874e-05
|
|
|
RP14
|
[NCBI]
|
8.18874e-05
|
|
|
hyperalphalipoproteinemia
|
[NCBI]
|
8.18874e-05
|
|
|
ATCAY
|
[NCBI]
|
8.18874e-05
|
|
|
EVA
|
[NCBI]
|
7.90045e-05
|
|
|
TH
|
[NCBI]
|
7.88062e-05
|
|
|
FBS
|
[NCBI]
|
7.87733e-05
|
|
|
alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity
|
[NCBI]
|
7.83856e-05
|
|
|
porphyria cutanea tarda, type i
|
[NCBI]
|
7.83856e-05
|
|
|
EPM3
|
[NCBI]
|
7.83856e-05
|
|
|
CDG1L
|
[NCBI]
|
7.83856e-05
|
|
|
transaldolase deficiency
|
[NCBI]
|
7.83856e-05
|
|
|
metachondromatosis
|
[NCBI]
|
7.83856e-05
|
|
|
CATCN3
|
[NCBI]
|
7.83856e-05
|
|
|
CISS1
|
[NCBI]
|
7.83856e-05
|
|
|
immunodeficiency due to defect in cd3-zeta
|
[NCBI]
|
7.83856e-05
|
|
|
aphakia, congenital primary
|
[NCBI]
|
7.83856e-05
|
|
|
NPHS3
|
[NCBI]
|
7.83856e-05
|
|
|
chondrodysplasia, acromesomelic, with genital anomalies
|
[NCBI]
|
7.83856e-05
|
|
|
fertile eunuch syndrome
|
[NCBI]
|
7.83856e-05
|
|
|
mitochondrial phosphate carrier deficiency
|
[NCBI]
|
7.83856e-05
|
|
|
DFNB53
|
[NCBI]
|
7.83856e-05
|
|
|
deafness, congenital, with inner ear agenesis, microtia, and microdontia
|
[NCBI]
|
7.83856e-05
|
|
|
dopamine beta-hydroxylase, plasma, thermolability of
|
[NCBI]
|
7.83856e-05
|
|
|
LCCS3
|
[NCBI]
|
7.83856e-05
|
|
|
cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome
|
[NCBI]
|
7.83856e-05
|
|
|
RCD3B
|
[NCBI]
|
7.83856e-05
|
|
|
CDG2E
|
[NCBI]
|
7.83856e-05
|
|
|
thyroid hormone metabolism, abnormal
|
[NCBI]
|
7.83856e-05
|
|
|
blood group--en
|
[NCBI]
|
7.83856e-05
|
|
|
RP36
|
[NCBI]
|
7.83856e-05
|
|
|
hypotrichosis-lymphedema-telangiectasia syndrome
|
[NCBI]
|
7.83856e-05
|
|
|
POF2B
|
[NCBI]
|
7.83856e-05
|
|
|
carabelli anomaly of maxillary molar teeth
|
[NCBI]
|
7.83856e-05
|
|
|
cortical dysplasia-focal epilepsy syndrome
|
[NCBI]
|
7.83856e-05
|
|
|
SMN2
|
[NCBI]
|
7.81712e-05
|
|
|
AR
|
[NCBI]
|
7.69335e-05
|
|
|
ALD
|
[NCBI]
|
7.52151e-05
|
|
|
kartagener syndrome
|
[NCBI]
|
7.49477e-05
|
|
|
SMA3
|
[NCBI]
|
7.49477e-05
|
|
|
WFS1
|
[NCBI]
|
7.49477e-05
|
|
|
CCA2
|
[NCBI]
|
7.49028e-05
|
|
|
FMO2
|
[NCBI]
|
7.49028e-05
|
|
|
LGMD2J
|
[NCBI]
|
7.49028e-05
|
|
|
CHAT
|
[NCBI]
|
7.42327e-05
|
|
|
JARID2
|
[NCBI]
|
7.41322e-05
|
|
|
LYST
|
[NCBI]
|
7.41322e-05
|
|
|
FRDA
|
[NCBI]
|
7.32386e-05
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
7.26877e-05
|
|
|
CAT
|
[NCBI]
|
7.21269e-05
|
|
|
ALAD
|
[NCBI]
|
7.08079e-05
|
|
|
CFH
|
[NCBI]
|
7.02941e-05
|
|
|
osteogenesis imperfecta, type iii
|
[NCBI]
|
6.99209e-05
|
|
|
CHED2
|
[NCBI]
|
6.90803e-05
|
|
|
mal de meleda
|
[NCBI]
|
6.90803e-05
|
|
|
cryptorchidism, unilateral or bilateral
|
[NCBI]
|
6.90803e-05
|
|
|
ACHM3
|
[NCBI]
|
6.90803e-05
|
|
|
APOB
|
[NCBI]
|
6.81282e-05
|
|
|
SLC4A1
|
[NCBI]
|
6.76759e-05
|
|
|
HPS3
|
[NCBI]
|
6.74514e-05
|
|
|
TNFSF6
|
[NCBI]
|
6.73979e-05
|
|
|
MBP
|
[NCBI]
|
6.67347e-05
|
|
|
LHCGR
|
[NCBI]
|
6.61333e-05
|
|
|
CDSP
|
[NCBI]
|
6.59604e-05
|
|
|
MPO
|
[NCBI]
|
6.59404e-05
|
|
|
PXE
|
[NCBI]
|
6.55181e-05
|
|
|
LAMA3
|
[NCBI]
|
6.52524e-05
|
|
|
niemann-pick disease, type a
|
[NCBI]
|
6.48499e-05
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
6.42366e-05
|
|
|
osteogenic sarcoma
|
[NCBI]
|
6.41017e-05
|
|
|
RP12
|
[NCBI]
|
6.41017e-05
|
|
|
complement factor i deficiency
|
[NCBI]
|
6.41017e-05
|
|
|
OCA3
|
[NCBI]
|
6.41017e-05
|
|
|
DMC
|
[NCBI]
|
6.41017e-05
|
|
|
CLPED1
|
[NCBI]
|
6.41017e-05
|
|
|
NPHP3
|
[NCBI]
|
6.41017e-05
|
|
|
corticosteroid-binding globulin deficiency
|
[NCBI]
|
6.41017e-05
|
|
|
GNRHR
|
[NCBI]
|
6.40098e-05
|
|
|
F2
|
[NCBI]
|
6.40098e-05
|
|
|
DGUOK
|
[NCBI]
|
6.27716e-05
|
|
|
HBD
|
[NCBI]
|
6.26629e-05
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
6.25171e-05
|
|
|
gaucher disease, type iii
|
[NCBI]
|
6.03038e-05
|
|
|
afibrinogenemia, congenital
|
[NCBI]
|
5.97643e-05
|
|
|
corneal dystrophy, gelatinous drop-like
|
[NCBI]
|
5.97643e-05
|
|
|
CLN8
|
[NCBI]
|
5.97643e-05
|
|
|
SCA6
|
[NCBI]
|
5.83049e-05
|
|
|
LWD
|
[NCBI]
|
5.83049e-05
|
|
|
SMA2
|
[NCBI]
|
5.81998e-05
|
|
|
CYP17A1
|
[NCBI]
|
5.81759e-05
|
|
|
AVP
|
[NCBI]
|
5.80285e-05
|
|
|
PD
|
[NCBI]
|
5.75673e-05
|
|
|
homocystinuria
|
[NCBI]
|
5.68426e-05
|
|
|
HBFQTL1
|
[NCBI]
|
5.61964e-05
|
|
|
galactokinase deficiency
|
[NCBI]
|
5.5931e-05
|
|
|
SCAR1
|
[NCBI]
|
5.5931e-05
|
|
|
OSMED
|
[NCBI]
|
5.5931e-05
|
|
|
WS3
|
[NCBI]
|
5.5931e-05
|
|
|
von willebrand disease
|
[NCBI]
|
5.55589e-05
|
|
|
CASR
|
[NCBI]
|
5.5504e-05
|
|
|
INVS
|
[NCBI]
|
5.49441e-05
|
|
|
WAS
|
[NCBI]
|
5.48887e-05
|
|
|
TSD
|
[NCBI]
|
5.46958e-05
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
5.42859e-05
|
|
|
TUSC2
|
[NCBI]
|
5.38437e-05
|
|
|
DHFR
|
[NCBI]
|
5.35263e-05
|
|
|
HHF2
|
[NCBI]
|
5.29429e-05
|
|
|
AK1
|
[NCBI]
|
5.2933e-05
|
|
|
NPPA
|
[NCBI]
|
5.27948e-05
|
|
|
UCHL3
|
[NCBI]
|
5.25876e-05
|
|
|
CDA
|
[NCBI]
|
5.25045e-05
|
|
|
SACS
|
[NCBI]
|
5.25045e-05
|
|
|
carbamoyl phosphate synthetase i deficiency, hyperammonemia due to
|
[NCBI]
|
5.25045e-05
|
|
|
ALUNC
|
[NCBI]
|
5.25045e-05
|
|
|
SMA4
|
[NCBI]
|
5.25045e-05
|
|
|
LGMD2H
|
[NCBI]
|
5.25045e-05
|
|
|
PMDS
|
[NCBI]
|
5.25045e-05
|
|
|
apolipoprotein c-ii deficiency
|
[NCBI]
|
5.25045e-05
|
|
|
lipoid proteinosis of urbach and wiethe
|
[NCBI]
|
5.25045e-05
|
|
|
WS1
|
[NCBI]
|
5.16934e-05
|
|
|
LOCS
|
[NCBI]
|
5.10161e-05
|
|
|
cholesteryl ester transfer protein deficiency
|
[NCBI]
|
5.10161e-05
|
|
|
SIDDT
|
[NCBI]
|
5.10161e-05
|
|
|
cleft lip/palate with abnormal thumbs and microcephaly
|
[NCBI]
|
5.10161e-05
|
|
|
caspase 8 deficiency
|
[NCBI]
|
5.10161e-05
|
|
|
bruck syndrome 2
|
[NCBI]
|
5.10161e-05
|
|
|
peeling skin syndrome, acral type
|
[NCBI]
|
5.10161e-05
|
|
|
eem syndrome
|
[NCBI]
|
5.10161e-05
|
|
|
parkinson-dementia syndrome
|
[NCBI]
|
5.10161e-05
|
|
|
SLSN4
|
[NCBI]
|
5.10161e-05
|
|
|
retinopathy, pigmentary, and mental retardation
|
[NCBI]
|
5.10161e-05
|
|
|
CMH8
|
[NCBI]
|
5.10161e-05
|
|
|
JBTS4
|
[NCBI]
|
5.10161e-05
|
|
|
MRT6
|
[NCBI]
|
5.10161e-05
|
|
|
craniofacial dysmorphism with ocular coloboma, absent corpus callosum, and aortic dilatation
|
[NCBI]
|
5.10161e-05
|
|
|
glycinuria with or without oxalate urolithiasis
|
[NCBI]
|
5.10161e-05
|
|
|
abcd syndrome
|
[NCBI]
|
5.10161e-05
|
|
|
methylmalonyl-coa epimerase deficiency
|
[NCBI]
|
5.10161e-05
|
|
|
LCCS2
|
[NCBI]
|
5.10161e-05
|
|
|
MCPH3
|
[NCBI]
|
5.10161e-05
|
|
|
t-cell subgroups, non-hla-linked
|
[NCBI]
|
5.10161e-05
|
|
|
magnesium, elevated red cell
|
[NCBI]
|
5.10161e-05
|
|
|
hypercholesterolemia, autosomal dominant, type b
|
[NCBI]
|
5.10161e-05
|
|
|
AOIII
|
[NCBI]
|
5.10161e-05
|
|
|
chorea, benign familial
|
[NCBI]
|
5.10161e-05
|
|
|
TSHB
|
[NCBI]
|
5.04916e-05
|
|
|
TRIM32
|
[NCBI]
|
4.96054e-05
|
|
|
alzheimer disease 2
|
[NCBI]
|
4.94134e-05
|
|
|
galactose epimerase deficiency
|
[NCBI]
|
4.94134e-05
|
|
|
thiopurine s-methyltransferase deficiency
|
[NCBI]
|
4.94134e-05
|
|
|
ACCPN
|
[NCBI]
|
4.94134e-05
|
|
|
epidermolysis bullosa simplex and limb-girdle muscular dystrophy
|
[NCBI]
|
4.94134e-05
|
|
|
amyloidosis v
|
[NCBI]
|
4.94134e-05
|
|
|
NCIE1
|
[NCBI]
|
4.94134e-05
|
|
|
VHL
|
[NCBI]
|
4.8363e-05
|
|
|
FANCA
|
[NCBI]
|
4.7969e-05
|
|
|
TPI1
|
[NCBI]
|
4.72285e-05
|
|
|
ADRB2
|
[NCBI]
|
4.72285e-05
|
|
|
TS
|
[NCBI]
|
4.69396e-05
|
|
|
HR
|
[NCBI]
|
4.68028e-05
|
|
|
GCCD1
|
[NCBI]
|
4.66035e-05
|
|
|
mucopolysaccharidosis type iiic
|
[NCBI]
|
4.66035e-05
|
|
|
SPD1
|
[NCBI]
|
4.66035e-05
|
|
|
JLNS1
|
[NCBI]
|
4.66035e-05
|
|
|
USH1C
|
[NCBI]
|
4.66035e-05
|
|
|
LGMD1B
|
[NCBI]
|
4.66035e-05
|
|
|
TPMT
|
[NCBI]
|
4.64508e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
4.63766e-05
|
|
|
RTT
|
[NCBI]
|
4.60536e-05
|
|
|
ATP7B
|
[NCBI]
|
4.58101e-05
|
|
|
MC2R
|
[NCBI]
|
4.57028e-05
|
|
|
FA
|
[NCBI]
|
4.56298e-05
|
|
|
RB1
|
[NCBI]
|
4.51624e-05
|
|
|
tibial muscular dystrophy, tardive
|
[NCBI]
|
4.40327e-05
|
|
|
nondisjunction
|
[NCBI]
|
4.40327e-05
|
|
|
MCPH1
|
[NCBI]
|
4.40327e-05
|
|
|
myasthenic syndrome, congenital, associated with episodic apnea
|
[NCBI]
|
4.40327e-05
|
|
|
LGMD2B
|
[NCBI]
|
4.40327e-05
|
|
|
HEXB
|
[NCBI]
|
4.38239e-05
|
|
|
PMM2
|
[NCBI]
|
4.36613e-05
|
|
|
PINK1
|
[NCBI]
|
4.36613e-05
|
|
|
POLG
|
[NCBI]
|
4.31961e-05
|
|
|
NPHP1
|
[NCBI]
|
4.29401e-05
|
|
|
AS
|
[NCBI]
|
4.28482e-05
|
|
|
FKRP
|
[NCBI]
|
4.27108e-05
|
|
|
SLC3A1
|
[NCBI]
|
4.27108e-05
|
|
|
PPM1B
|
[NCBI]
|
4.25478e-05
|
|
|
LMNA
|
[NCBI]
|
4.21727e-05
|
|
|
LPL
|
[NCBI]
|
4.16826e-05
|
|
|
FED
|
[NCBI]
|
4.16681e-05
|
|
|
hartnup disorder
|
[NCBI]
|
4.16681e-05
|
|
|
PPAC
|
[NCBI]
|
4.16681e-05
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
4.16681e-05
|
|
|
vitamin d-dependent rickets, type ii
|
[NCBI]
|
4.16486e-05
|
|
|
IDDM
|
[NCBI]
|
4.15825e-05
|
|
|
SLC7A9
|
[NCBI]
|
4.12049e-05
|
|
|
MCPH6
|
[NCBI]
|
4.09374e-05
|
|
|
polydactyly
|
[NCBI]
|
4.09374e-05
|
|
|
OODD
|
[NCBI]
|
4.09374e-05
|
|
|
ABSD
|
[NCBI]
|
4.09374e-05
|
|
|
fibular hypoplasia and complex brachydactyly
|
[NCBI]
|
4.09374e-05
|
|
|
spherocytosis, autosomal recessive
|
[NCBI]
|
4.09374e-05
|
|
|
DFNB21
|
[NCBI]
|
4.09374e-05
|
|
|
icos deficiency
|
[NCBI]
|
4.09374e-05
|
|
|
abdominal body fat distribution
|
[NCBI]
|
4.09374e-05
|
|
|
S CHOICE OF
|
[NCBI]
|
4.09374e-05
|
|
|
lathosterolosis
|
[NCBI]
|
4.09374e-05
|
|
|
DFNB31
|
[NCBI]
|
4.09374e-05
|
|
|
phosphoglycerate dehydrogenase deficiency
|
[NCBI]
|
4.09374e-05
|
|
|
PLT1
|
[NCBI]
|
4.09374e-05
|
|
|
angioid streaks
|
[NCBI]
|
4.09374e-05
|
|
|
ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis
|
[NCBI]
|
4.09374e-05
|
|
|
ovarian teratoma
|
[NCBI]
|
4.09374e-05
|
|
|
majeed syndrome
|
[NCBI]
|
4.09374e-05
|
|
|
NEK1
|
[NCBI]
|
4.09374e-05
|
|
|
HJMD
|
[NCBI]
|
4.09374e-05
|
|
|
amelogenesis imperfecta, hypoplastic, and openbite malocclusion, autosomal recessive
|
[NCBI]
|
4.09374e-05
|
|
|
SMC
|
[NCBI]
|
4.09374e-05
|
|
|
hepatitis b vaccine, response to
|
[NCBI]
|
4.09374e-05
|
|
|
camptodactyly, tall stature, and hearing loss syndrome
|
[NCBI]
|
4.09374e-05
|
|
|
CMD1P
|
[NCBI]
|
4.09374e-05
|
|
|
LCA10
|
[NCBI]
|
4.09374e-05
|
|
|
OCA1A
|
[NCBI]
|
4.03343e-05
|
|
|
ZS
|
[NCBI]
|
4.02385e-05
|
|
|
PROP1
|
[NCBI]
|
4.00962e-05
|
|
|
MTAP
|
[NCBI]
|
3.9737e-05
|
|
|
factor vii deficiency
|
[NCBI]
|
3.9737e-05
|
|
|
MKKS
|
[NCBI]
|
3.94827e-05
|
|
|
PHA
|
[NCBI]
|
3.94827e-05
|
|
|
CORD2
|
[NCBI]
|
3.94827e-05
|
|
|
molybdenum cofactor deficiency
|
[NCBI]
|
3.94827e-05
|
|
|
diarrhea 1, secretory chloride, congenital
|
[NCBI]
|
3.94827e-05
|
|
|
blood group, p system
|
[NCBI]
|
3.94827e-05
|
|
|
AHR
|
[NCBI]
|
3.94562e-05
|
|
|
COL17A1
|
[NCBI]
|
3.9294e-05
|
|
|
CDK4
|
[NCBI]
|
3.91882e-05
|
|
|
GHR
|
[NCBI]
|
3.83549e-05
|
|
|
HLA-C
|
[NCBI]
|
3.82045e-05
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
3.81259e-05
|
|
|
LPI
|
[NCBI]
|
3.80778e-05
|
|
|
HHF1
|
[NCBI]
|
3.78463e-05
|
|
|
MODY
|
[NCBI]
|
3.77871e-05
|
|
|
EDN3
|
[NCBI]
|
3.7779e-05
|
|
|
ITGA9
|
[NCBI]
|
3.7478e-05
|
|
|
PEX16
|
[NCBI]
|
3.7478e-05
|
|
|
PREPL
|
[NCBI]
|
3.7478e-05
|
|
|
pituitary dwarfism i
|
[NCBI]
|
3.74547e-05
|
|
|
CETP
|
[NCBI]
|
3.70623e-05
|
|
|
SMAD4
|
[NCBI]
|
3.70623e-05
|
|
|
FUT1
|
[NCBI]
|
3.68895e-05
|
|
|
S100A8
|
[NCBI]
|
3.68895e-05
|
|
|
CLEC4M
|
[NCBI]
|
3.68895e-05
|
|
|
C3
|
[NCBI]
|
3.67193e-05
|
|
|
RECQL3
|
[NCBI]
|
3.63704e-05
|
|
|
MBL2
|
[NCBI]
|
3.62734e-05
|
|
|
LEP
|
[NCBI]
|
3.60485e-05
|
|
|
SLC2A2
|
[NCBI]
|
3.5795e-05
|
|
|
AGL
|
[NCBI]
|
3.56739e-05
|
|
|
NPHP1
|
[NCBI]
|
3.55662e-05
|
|
|
pyruvate kinase deficiency of red cells
|
[NCBI]
|
3.55299e-05
|
|
|
glycogen storage disease ii
|
[NCBI]
|
3.55016e-05
|
|
|
HLA-A
|
[NCBI]
|
3.51629e-05
|
|
|
BDNF
|
[NCBI]
|
3.50812e-05
|
|
|
GLB1
|
[NCBI]
|
3.50554e-05
|
|
|
PPOX
|
[NCBI]
|
3.50554e-05
|
|
|
GAPDH
|
[NCBI]
|
3.46274e-05
|
|
|
SGCA
|
[NCBI]
|
3.45443e-05
|
|
|
CYP2C9
|
[NCBI]
|
3.45443e-05
|
|
|
IGAD2
|
[NCBI]
|
3.45341e-05
|
|
|
laurence-moon syndrome
|
[NCBI]
|
3.45341e-05
|
|
|
bartter syndrome, antenatal, type 1
|
[NCBI]
|
3.45341e-05
|
|
|
glutathione synthetase deficiency of erythrocytes, hemolytic anemia due to
|
[NCBI]
|
3.45341e-05
|
|
|
charcot-marie-tooth disease, recessive intermediate a
|
[NCBI]
|
3.45341e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, infantile
|
[NCBI]
|
3.45341e-05
|
|
|
CFEOM2
|
[NCBI]
|
3.45341e-05
|
|
|
MLASA
|
[NCBI]
|
3.45341e-05
|
|
|
fragile site 17p12
|
[NCBI]
|
3.45341e-05
|
|
|
caudal duplication anomaly
|
[NCBI]
|
3.45341e-05
|
|
|
myxoma, intracardiac
|
[NCBI]
|
3.45341e-05
|
|
|
epidermolysis bullosa simplex, ogna type
|
[NCBI]
|
3.45341e-05
|
|
|
resting heart rate
|
[NCBI]
|
3.45341e-05
|
|
|
RP18
|
[NCBI]
|
3.45341e-05
|
|
|
USH1G
|
[NCBI]
|
3.45341e-05
|
|
|
CMT4H
|
[NCBI]
|
3.45341e-05
|
|
|
bare lymphocyte syndrome, type i
|
[NCBI]
|
3.45341e-05
|
|
|
lactase deficiency, congenital
|
[NCBI]
|
3.45341e-05
|
|
|
weill-marchesani syndrome, autosomal dominant
|
[NCBI]
|
3.45341e-05
|
|
|
USH1F
|
[NCBI]
|
3.45341e-05
|
|
|
PURE&apos
|
[NCBI]
|
3.45341e-05
|
|
|
DFNB59
|
[NCBI]
|
3.45341e-05
|
|
|
RP19
|
[NCBI]
|
3.45341e-05
|
|
|
hydroxyprolinemia
|
[NCBI]
|
3.45341e-05
|
|
|
hyperlysinemia
|
[NCBI]
|
3.45341e-05
|
|
|
segawa syndrome, autosomal recessive
|
[NCBI]
|
3.45341e-05
|
|
|
CDKN2A
|
[NCBI]
|
3.42694e-05
|
|
|
ITGB3
|
[NCBI]
|
3.40521e-05
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
3.40521e-05
|
|
|
HYAL1
|
[NCBI]
|
3.40179e-05
|
|
|
CSMD1
|
[NCBI]
|
3.40179e-05
|
|
|
C1S
|
[NCBI]
|
3.40179e-05
|
|
|
ECEL1
|
[NCBI]
|
3.40179e-05
|
|
|
MYO7A
|
[NCBI]
|
3.38232e-05
|
|
|
EL1
|
[NCBI]
|
3.38019e-05
|
|
|
MSS
|
[NCBI]
|
3.38019e-05
|
|
|
RNASEL
|
[NCBI]
|
3.34899e-05
|
|
|
RAD51
|
[NCBI]
|
3.34899e-05
|
|
|
PAX1
|
[NCBI]
|
3.34899e-05
|
|
|
HBA2
|
[NCBI]
|
3.34871e-05
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
3.3368e-05
|
|
|
SLC26A4
|
[NCBI]
|
3.32352e-05
|
|
|
RECQL2
|
[NCBI]
|
3.26647e-05
|
|
|
wolman disease
|
[NCBI]
|
3.26647e-05
|
|
|
MAFD2
|
[NCBI]
|
3.25033e-05
|
|
|
UCHL1
|
[NCBI]
|
3.25017e-05
|
|
|
PTS
|
[NCBI]
|
3.25017e-05
|
|
|
GLC3A
|
[NCBI]
|
3.2149e-05
|
|
|
CGL2
|
[NCBI]
|
3.2149e-05
|
|
|
gm1-gangliosidosis, type i
|
[NCBI]
|
3.2149e-05
|
|
|
UCMD
|
[NCBI]
|
3.2149e-05
|
|
|
ADRB3
|
[NCBI]
|
3.15724e-05
|
|
|
COL11A2
|
[NCBI]
|
3.15724e-05
|
|
|
ECM1
|
[NCBI]
|
3.15724e-05
|
|
|
KIR2DL3
|
[NCBI]
|
3.13815e-05
|
|
|
MPV17
|
[NCBI]
|
3.13815e-05
|
|
|
HSD17B3
|
[NCBI]
|
3.13815e-05
|
|
|
TALDO1
|
[NCBI]
|
3.13815e-05
|
|
|
ARL6
|
[NCBI]
|
3.13815e-05
|
|
|
ALG6
|
[NCBI]
|
3.13815e-05
|
|
|
AGPAT2
|
[NCBI]
|
3.13815e-05
|
|
|
GIST
|
[NCBI]
|
3.1324e-05
|
|
|
TTR
|
[NCBI]
|
3.1043e-05
|
|
|
DHCR7
|
[NCBI]
|
3.06956e-05
|
|
|
donohue syndrome
|
[NCBI]
|
3.05967e-05
|
|
|
MDC1A
|
[NCBI]
|
3.05967e-05
|
|
|
CHAC
|
[NCBI]
|
3.05967e-05
|
|
|
ABCA4
|
[NCBI]
|
3.05399e-05
|
|
|
PPARA
|
[NCBI]
|
3.05204e-05
|
|
|
CPI
|
[NCBI]
|
3.04189e-05
|
|
|
MC1R
|
[NCBI]
|
3.00211e-05
|
|
|
urogenital adysplasia, hereditary
|
[NCBI]
|
2.99387e-05
|
|
|
RCDP3
|
[NCBI]
|
2.98764e-05
|
|
|
hyperprolinemia, type ii
|
[NCBI]
|
2.98764e-05
|
|
|
fragile site 10q25
|
[NCBI]
|
2.98764e-05
|
|
|
RCD3A
|
[NCBI]
|
2.98764e-05
|
|
|
CACP
|
[NCBI]
|
2.98764e-05
|
|
|
niemann-pick disease, type c2
|
[NCBI]
|
2.98764e-05
|
|
|
schindler disease, type i
|
[NCBI]
|
2.98764e-05
|
|
|
PFIC2
|
[NCBI]
|
2.98764e-05
|
|
|
n-acetylglutamate synthase deficiency
|
[NCBI]
|
2.98764e-05
|
|
|
NEM1
|
[NCBI]
|
2.98764e-05
|
|
|
anemia, hypochromic microcytic
|
[NCBI]
|
2.98764e-05
|
|
|
glycogen storage disease 0, muscle
|
[NCBI]
|
2.98764e-05
|
|
|
thrombophilia due to deficiency of activated protein c cofactor
|
[NCBI]
|
2.98764e-05
|
|
|
west nile virus, susceptibility to
|
[NCBI]
|
2.98764e-05
|
|
|
follicle-stimulating hormone deficiency, isolated
|
[NCBI]
|
2.98764e-05
|
|
|
DFNA13
|
[NCBI]
|
2.98764e-05
|
|
|
OUBR
|
[NCBI]
|
2.98764e-05
|
|
|
RTADR
|
[NCBI]
|
2.98764e-05
|
|
|
NN
|
[NCBI]
|
2.98764e-05
|
|
|
LI2
|
[NCBI]
|
2.98764e-05
|
|
|
renal tubular acidosis, proximal, with ocular abnormalities and mental retardation
|
[NCBI]
|
2.98764e-05
|
|
|
premature chromosome condensation with microcephaly and mental retardation
|
[NCBI]
|
2.98764e-05
|
|
|
mucopolysaccharidosis type iiid
|
[NCBI]
|
2.98764e-05
|
|
|
DFNB2
|
[NCBI]
|
2.98764e-05
|
|
|
spondylocarpotarsal synostosis syndrome
|
[NCBI]
|
2.98764e-05
|
|
|
cystinosis, adult nonnephropathic
|
[NCBI]
|
2.98764e-05
|
|
|
DFNB6
|
[NCBI]
|
2.98764e-05
|
|
|
NPHP4
|
[NCBI]
|
2.98764e-05
|
|
|
budd-chiari syndrome
|
[NCBI]
|
2.98764e-05
|
|
|
beta thalassemia, dominant inclusion body type
|
[NCBI]
|
2.98764e-05
|
|
|
AH
|
[NCBI]
|
2.98764e-05
|
|
|
shprintzen-goldberg craniosynostosis syndrome
|
[NCBI]
|
2.98764e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive
|
[NCBI]
|
2.98764e-05
|
|
|
thyroid hormonogenesis, genetic defect in, 1
|
[NCBI]
|
2.98764e-05
|
|
|
LCA2
|
[NCBI]
|
2.98764e-05
|
|
|
PDB1
|
[NCBI]
|
2.98764e-05
|
|
|
mitochondrial complex ii deficiency
|
[NCBI]
|
2.98764e-05
|
|
|
renal tubular acidosis, distal, with hemolytic anemia
|
[NCBI]
|
2.98764e-05
|
|
|
CLN3
|
[NCBI]
|
2.98661e-05
|
|
|
CPT2
|
[NCBI]
|
2.98661e-05
|
|
|
FTO
|
[NCBI]
|
2.92521e-05
|
|
|
HAND1
|
[NCBI]
|
2.92521e-05
|
|
|
SLURP1
|
[NCBI]
|
2.92521e-05
|
|
|
C1QG
|
[NCBI]
|
2.92521e-05
|
|
|
CLN8
|
[NCBI]
|
2.92521e-05
|
|
|
ARIX
|
[NCBI]
|
2.92521e-05
|
|
|
FGA
|
[NCBI]
|
2.91865e-05
|
|
|
CSNB1A
|
[NCBI]
|
2.91356e-05
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
2.91356e-05
|
|
|
glycogen storage disease iii
|
[NCBI]
|
2.91356e-05
|
|
|
diastrophic dysplasia
|
[NCBI]
|
2.91356e-05
|
|
|
HOXD13
|
[NCBI]
|
2.90793e-05
|
|
|
AMPD1
|
[NCBI]
|
2.90793e-05
|
|
|
FRAP1
|
[NCBI]
|
2.89502e-05
|
|
|
SHBG
|
[NCBI]
|
2.89488e-05
|
|
|
FSHMD1A
|
[NCBI]
|
2.87716e-05
|
|
|
PTK2
|
[NCBI]
|
2.8552e-05
|
|
|
galactosemia
|
[NCBI]
|
2.85485e-05
|
|
|
APOA1
|
[NCBI]
|
2.85277e-05
|
|
|
WFS1
|
[NCBI]
|
2.83314e-05
|
|
|
LAMB3
|
[NCBI]
|
2.83314e-05
|
|
|
XDH
|
[NCBI]
|
2.80992e-05
|
|
|
CMM2
|
[NCBI]
|
2.77575e-05
|
|
|
obesity
|
[NCBI]
|
2.76733e-05
|
|
|
sickle cell anemia
|
[NCBI]
|
2.76733e-05
|
|
|
LHB
|
[NCBI]
|
2.76189e-05
|
|
|
PCOS1
|
[NCBI]
|
2.75264e-05
|
|
|
PTHLH
|
[NCBI]
|
2.74768e-05
|
|
|
SIL1
|
[NCBI]
|
2.74679e-05
|
|
|
LPIN2
|
[NCBI]
|
2.74679e-05
|
|
|
TCF21
|
[NCBI]
|
2.74679e-05
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
2.74126e-05
|
|
|
SRD5A2
|
[NCBI]
|
2.69389e-05
|
|
|
dedicator of cytokinesis 4
|
[NCBI]
|
2.69207e-05
|
|
|
HSPA12B
|
[NCBI]
|
2.69207e-05
|
|
|
101f6 gene
|
[NCBI]
|
2.69207e-05
|
|
|
MOSPD3
|
[NCBI]
|
2.69207e-05
|
|
|
CISD2
|
[NCBI]
|
2.69207e-05
|
|
|
AASS
|
[NCBI]
|
2.69207e-05
|
|
|
KCTD7
|
[NCBI]
|
2.69207e-05
|
|
|
IZUMO1
|
[NCBI]
|
2.69207e-05
|
|
|
BBS12
|
[NCBI]
|
2.69207e-05
|
|
|
pl6 gene
|
[NCBI]
|
2.69207e-05
|
|
|
C2ORF34
|
[NCBI]
|
2.69207e-05
|
|
|
HOXA3
|
[NCBI]
|
2.69207e-05
|
|
|
MFSD8
|
[NCBI]
|
2.69207e-05
|
|
|
SERF2
|
[NCBI]
|
2.69207e-05
|
|
|
MOSPD1
|
[NCBI]
|
2.69207e-05
|
|
|
FEA
|
[NCBI]
|
2.69207e-05
|
|
|
TUSC1
|
[NCBI]
|
2.69207e-05
|
|
|
TUSC4
|
[NCBI]
|
2.69207e-05
|
|
|
SPATA16
|
[NCBI]
|
2.69207e-05
|
|
|
PLCL1
|
[NCBI]
|
2.69207e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
2.67687e-05
|
|
|
LS
|
[NCBI]
|
2.67687e-05
|
|
|
HS
|
[NCBI]
|
2.64993e-05
|
|
|
ATM
|
[NCBI]
|
2.64977e-05
|
|
|
PBD
|
[NCBI]
|
2.64554e-05
|
|
|
GALC
|
[NCBI]
|
2.62888e-05
|
|
|
pta deficiency
|
[NCBI]
|
2.62888e-05
|
|
|
l-2-hydroxyglutaric aciduria
|
[NCBI]
|
2.62468e-05
|
|
|
MRT1
|
[NCBI]
|
2.62468e-05
|
|
|
paget disease, juvenile
|
[NCBI]
|
2.62468e-05
|
|
|
FANCD1
|
[NCBI]
|
2.62468e-05
|
|
|
OCA4
|
[NCBI]
|
2.62468e-05
|
|
|
gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to
|
[NCBI]
|
2.62468e-05
|
|
|
LGMD2F
|
[NCBI]
|
2.62468e-05
|
|
|
naxos disease
|
[NCBI]
|
2.62468e-05
|
|
|
thrombophilia
|
[NCBI]
|
2.62468e-05
|
|
|
oguchi disease
|
[NCBI]
|
2.62468e-05
|
|
|
osseous heteroplasia, progressive
|
[NCBI]
|
2.62468e-05
|
|
|
RCDP2
|
[NCBI]
|
2.62468e-05
|
|
|
ectodermal dysplasia/skin fragility syndrome
|
[NCBI]
|
2.62468e-05
|
|
|
CGL1
|
[NCBI]
|
2.62468e-05
|
|
|
corticosterone methyloxidase type i deficiency
|
[NCBI]
|
2.62468e-05
|
|
|
CMRD
|
[NCBI]
|
2.62468e-05
|
|
|
ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant
|
[NCBI]
|
2.62468e-05
|
|
|
boomerang dysplasia
|
[NCBI]
|
2.62468e-05
|
|
|
hemoglobin--variants for which the chain carrying the mutation is unknown or uncertain
|
[NCBI]
|
2.62468e-05
|
|
|
tyrosinemia, type iii
|
[NCBI]
|
2.62468e-05
|
|
|
USH2C
|
[NCBI]
|
2.62468e-05
|
|
|
F13A1
|
[NCBI]
|
2.61017e-05
|
|
|
TK2
|
[NCBI]
|
2.59342e-05
|
|
|
LAMC2
|
[NCBI]
|
2.59342e-05
|
|
|
PRH2
|
[NCBI]
|
2.59342e-05
|
|
|
BSCL2
|
[NCBI]
|
2.59342e-05
|
|
|
DMD
|
[NCBI]
|
2.56795e-05
|
|
|
SLC22A5
|
[NCBI]
|
2.56662e-05
|
|
|
GSTM1
|
[NCBI]
|
2.56662e-05
|
|
|
osteoarthritis
|
[NCBI]
|
2.52231e-05
|
|
|
ALMS
|
[NCBI]
|
2.52231e-05
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
2.52036e-05
|
|
|
CHRNE
|
[NCBI]
|
2.50692e-05
|
|
|
GNRH1
|
[NCBI]
|
2.46189e-05
|
|
|
KCNJ6
|
[NCBI]
|
2.45909e-05
|
|
|
GSTT1
|
[NCBI]
|
2.45909e-05
|
|
|
CDH3
|
[NCBI]
|
2.45909e-05
|
|
|
LMBR1
|
[NCBI]
|
2.45909e-05
|
|
|
CLDN16
|
[NCBI]
|
2.45909e-05
|
|
|
FGF5
|
[NCBI]
|
2.45909e-05
|
|
|
ATP8B1
|
[NCBI]
|
2.45909e-05
|
|
|
HTRA1
|
[NCBI]
|
2.45909e-05
|
|
|
ALMS1
|
[NCBI]
|
2.45909e-05
|
|
|
LMAN1
|
[NCBI]
|
2.45909e-05
|
|
|
FABP2
|
[NCBI]
|
2.44958e-05
|
|
|
KRT14
|
[NCBI]
|
2.44958e-05
|
|
|
RCDP1
|
[NCBI]
|
2.4055e-05
|
|
|
CHS
|
[NCBI]
|
2.39079e-05
|
|
|
HBA1
|
[NCBI]
|
2.3805e-05
|
|
|
hurler syndrome
|
[NCBI]
|
2.36768e-05
|
|
|
KCNJ11
|
[NCBI]
|
2.34138e-05
|
|
|
DPYD
|
[NCBI]
|
2.34138e-05
|
|
|
SECISBP2
|
[NCBI]
|
2.33974e-05
|
|
|
GP9
|
[NCBI]
|
2.33974e-05
|
|
|
INHA
|
[NCBI]
|
2.33974e-05
|
|
|
SGCG
|
[NCBI]
|
2.33974e-05
|
|
|
C1QA
|
[NCBI]
|
2.33974e-05
|
|
|
HADH
|
[NCBI]
|
2.33974e-05
|
|
|
PKP1
|
[NCBI]
|
2.33974e-05
|
|
|
cerebral palsy, spastic, symmetric, autosomal recessive
|
[NCBI]
|
2.32965e-05
|
|
|
CLN6
|
[NCBI]
|
2.32965e-05
|
|
|
cardiomyopathy, dilated, with woolly hair and keratoderma
|
[NCBI]
|
2.32965e-05
|
|
|
HMS
|
[NCBI]
|
2.32965e-05
|
|
|
SPMM
|
[NCBI]
|
2.32965e-05
|
|
|
agammaglobulinemia, non-bruton type, autosomal recessive
|
[NCBI]
|
2.32965e-05
|
|
|
MCOPS9
|
[NCBI]
|
2.32965e-05
|
|
|
three m syndrome
|
[NCBI]
|
2.32965e-05
|
|
|
palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal
|
[NCBI]
|
2.32965e-05
|
|
|
STL2
|
[NCBI]
|
2.32965e-05
|
|
|
EAD
|
[NCBI]
|
2.32965e-05
|
|
|
CO
|
[NCBI]
|
2.32965e-05
|
|
|
DSAP1
|
[NCBI]
|
2.32965e-05
|
|
|
CDG1C
|
[NCBI]
|
2.32965e-05
|
|
|
winchester syndrome
|
[NCBI]
|
2.32965e-05
|
|
|
acromesomelic dysplasia, hunter-thompson type
|
[NCBI]
|
2.32965e-05
|
|
|
aplastic anemia
|
[NCBI]
|
2.32965e-05
|
|
|
pierson syndrome
|
[NCBI]
|
2.32965e-05
|
|
|
WT5
|
[NCBI]
|
2.32965e-05
|
|
|
pemphigus vulgaris, familial
|
[NCBI]
|
2.32965e-05
|
|
|
ARMD7
|
[NCBI]
|
2.32965e-05
|
|
|
weill-marchesani syndrome, autosomal recessive
|
[NCBI]
|
2.32965e-05
|
|
|
INSR
|
[NCBI]
|
2.32632e-05
|
|
|
F3
|
[NCBI]
|
2.31313e-05
|
|
|
PPSH
|
[NCBI]
|
2.29464e-05
|
|
|
SPDA1
|
[NCBI]
|
2.29464e-05
|
|
|
POF1
|
[NCBI]
|
2.29464e-05
|
|
|
NOS3
|
[NCBI]
|
2.2884e-05
|
|
|
LEPR
|
[NCBI]
|
2.26694e-05
|
|
|
DYSF
|
[NCBI]
|
2.24088e-05
|
|
|
LCAT
|
[NCBI]
|
2.23402e-05
|
|
|
MYO15A
|
[NCBI]
|
2.23246e-05
|
|
|
FMN
|
[NCBI]
|
2.23246e-05
|
|
|
loc387715 gene
|
[NCBI]
|
2.23246e-05
|
|
|
HPS1
|
[NCBI]
|
2.23246e-05
|
|
|
SCN8A
|
[NCBI]
|
2.23246e-05
|
|
|
CX3CR1
|
[NCBI]
|
2.23246e-05
|
|
|
MERTK
|
[NCBI]
|
2.23246e-05
|
|
|
SPTA1
|
[NCBI]
|
2.22455e-05
|
|
|
WBS
|
[NCBI]
|
2.19515e-05
|
|
|
STGD1
|
[NCBI]
|
2.18928e-05
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
2.18928e-05
|
|
|
temporal arteritis
|
[NCBI]
|
2.15147e-05
|
|
|
GSN
|
[NCBI]
|
2.14718e-05
|
|
|
FCGR2B
|
[NCBI]
|
2.13514e-05
|
|
|
WWOX
|
[NCBI]
|
2.13514e-05
|
|
|
GDF11
|
[NCBI]
|
2.13514e-05
|
|
|
DYRK1A
|
[NCBI]
|
2.13514e-05
|
|
|
CYP2A6
|
[NCBI]
|
2.10262e-05
|
|
|
STL1
|
[NCBI]
|
2.08904e-05
|
|
|
cystathioninuria
|
[NCBI]
|
2.0829e-05
|
|
|
TRMA
|
[NCBI]
|
2.0829e-05
|
|
|
hyperprolinemia, type i
|
[NCBI]
|
2.0829e-05
|
|
|
FANCB
|
[NCBI]
|
2.0829e-05
|
|
|
HRD
|
[NCBI]
|
2.0829e-05
|
|
|
KCS
|
[NCBI]
|
2.0829e-05
|
|
|
HPS2
|
[NCBI]
|
2.0829e-05
|
|
|
globozoospermia
|
[NCBI]
|
2.0829e-05
|
|
|
AOI
|
[NCBI]
|
2.0829e-05
|
|
|
kuru, susceptibility to
|
[NCBI]
|
2.0829e-05
|
|
|
JBTS3
|
[NCBI]
|
2.0829e-05
|
|
|
MDC1C
|
[NCBI]
|
2.0829e-05
|
|
|
GS1
|
[NCBI]
|
2.0829e-05
|
|
|
vitiligo
|
[NCBI]
|
2.0829e-05
|
|
|
EPD
|
[NCBI]
|
2.0829e-05
|
|
|
CMT4B1
|
[NCBI]
|
2.0829e-05
|
|
|
coproporphyria
|
[NCBI]
|
2.05949e-05
|
|
|
CDX2
|
[NCBI]
|
2.04618e-05
|
|
|
EIF2B5
|
[NCBI]
|
2.04618e-05
|
|
|
NCF2
|
[NCBI]
|
2.04618e-05
|
|
|
RASSF1
|
[NCBI]
|
2.04618e-05
|
|
|
PVRL1
|
[NCBI]
|
2.04618e-05
|
|
|
HLCS
|
[NCBI]
|
2.04618e-05
|
|
|
COL9A1
|
[NCBI]
|
2.04618e-05
|
|
|
NQO1
|
[NCBI]
|
2.04618e-05
|
|
|
prekallikrein deficiency
|
[NCBI]
|
2.04618e-05
|
|
|
ACADS
|
[NCBI]
|
2.0177e-05
|
|
|
ASPA
|
[NCBI]
|
2.0177e-05
|
|
|
APOC2
|
[NCBI]
|
2.0177e-05
|
|
|
RBS
|
[NCBI]
|
1.99358e-05
|
|
|
PTPRC
|
[NCBI]
|
1.97718e-05
|
|
|
PDE6B
|
[NCBI]
|
1.97718e-05
|
|
|
MC4R
|
[NCBI]
|
1.96495e-05
|
|
|
BCKDHA
|
[NCBI]
|
1.96431e-05
|
|
|
P2RX7
|
[NCBI]
|
1.96431e-05
|
|
|
PRX
|
[NCBI]
|
1.96431e-05
|
|
|
BTD
|
[NCBI]
|
1.96431e-05
|
|
|
SPP1
|
[NCBI]
|
1.96122e-05
|
|
|
THRB
|
[NCBI]
|
1.93859e-05
|
|
|
RHCE
|
[NCBI]
|
1.93787e-05
|
|
|
AGTR1
|
[NCBI]
|
1.93787e-05
|
|
|
EDNRB
|
[NCBI]
|
1.93787e-05
|
|
|
CJD
|
[NCBI]
|
1.92218e-05
|
|
|
LRRK2
|
[NCBI]
|
1.91268e-05
|
|
|
DJS
|
[NCBI]
|
1.90258e-05
|
|
|
FY
|
[NCBI]
|
1.8997e-05
|
|
|
SLOS
|
[NCBI]
|
1.89705e-05
|
|
|
OTOF
|
[NCBI]
|
1.88857e-05
|
|
|
TULP1
|
[NCBI]
|
1.88857e-05
|
|
|
ME2
|
[NCBI]
|
1.88857e-05
|
|
|
KRTHB5
|
[NCBI]
|
1.87379e-05
|
|
|
TMIE
|
[NCBI]
|
1.87379e-05
|
|
|
COG7
|
[NCBI]
|
1.87379e-05
|
|
|
PRCD
|
[NCBI]
|
1.87379e-05
|
|
|
OTOA
|
[NCBI]
|
1.87379e-05
|
|
|
ichthyin
|
[NCBI]
|
1.87379e-05
|
|
|
ZMYND10
|
[NCBI]
|
1.87379e-05
|
|
|
TAS2R38
|
[NCBI]
|
1.87379e-05
|
|
|
TMEM113
|
[NCBI]
|
1.87379e-05
|
|
|
UNC13A
|
[NCBI]
|
1.87379e-05
|
|
|
TTC8
|
[NCBI]
|
1.87379e-05
|
|
|
SLC38A3
|
[NCBI]
|
1.87379e-05
|
|
|
BBS7
|
[NCBI]
|
1.87379e-05
|
|
|
NID2
|
[NCBI]
|
1.87379e-05
|
|
|
fus2 gene
|
[NCBI]
|
1.87379e-05
|
|
|
BAP1
|
[NCBI]
|
1.87379e-05
|
|
|
HSPA12A
|
[NCBI]
|
1.87379e-05
|
|
|
BCL2L2
|
[NCBI]
|
1.87379e-05
|
|
|
brain-specific protein pc-1
|
[NCBI]
|
1.87379e-05
|
|
|
CTPP4
|
[NCBI]
|
1.87379e-05
|
|
|
SERF1A
|
[NCBI]
|
1.87379e-05
|
|
|
KCNV2
|
[NCBI]
|
1.87379e-05
|
|
|
RAB36
|
[NCBI]
|
1.87379e-05
|
|
|
MCEE
|
[NCBI]
|
1.87379e-05
|
|
|
DVL1L1
|
[NCBI]
|
1.87379e-05
|
|
|
PRKAG3
|
[NCBI]
|
1.87379e-05
|
|
|
IFRD2
|
[NCBI]
|
1.87379e-05
|
|
|
fructose-1,6-bisphosphatase deficiency
|
[NCBI]
|
1.87226e-05
|
|
|
GGM
|
[NCBI]
|
1.87226e-05
|
|
|
iron overload in africa
|
[NCBI]
|
1.87226e-05
|
|
|
HFE3
|
[NCBI]
|
1.87226e-05
|
|
|
polydactyly, postaxial, type a1
|
[NCBI]
|
1.87226e-05
|
|
|
BOCD
|
[NCBI]
|
1.87226e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-negative
|
[NCBI]
|
1.87226e-05
|
|
|
GS2
|
[NCBI]
|
1.87226e-05
|
|
|
EDM4
|
[NCBI]
|
1.87226e-05
|
|
|
growth hormone insensitivity with immunodeficiency
|
[NCBI]
|
1.87226e-05
|
|
|
MODY2
|
[NCBI]
|
1.87226e-05
|
|
|
emanuel syndrome
|
[NCBI]
|
1.87226e-05
|
|
|
LRS1
|
[NCBI]
|
1.87226e-05
|
|
|
hydrops-ectopic calcification-moth-eaten skeletal dysplasia
|
[NCBI]
|
1.87226e-05
|
|
|
IS
|
[NCBI]
|
1.87226e-05
|
|
|
RHN
|
[NCBI]
|
1.87226e-05
|
|
|
sc phocomelia syndrome
|
[NCBI]
|
1.87226e-05
|
|
|
elliptocytosis, rhesus-unlinked type
|
[NCBI]
|
1.87226e-05
|
|
|
morquio syndrome b
|
[NCBI]
|
1.87226e-05
|
|
|
NSHPT
|
[NCBI]
|
1.87226e-05
|
|
|
3-@methylglutaconic aciduria, type i
|
[NCBI]
|
1.87226e-05
|
|
|
PARK2
|
[NCBI]
|
1.86215e-05
|
|
|
HGPS
|
[NCBI]
|
1.83836e-05
|
|
|
AIS
|
[NCBI]
|
1.83531e-05
|
|
|
HSCR1
|
[NCBI]
|
1.83112e-05
|
|
|
PANK2
|
[NCBI]
|
1.81814e-05
|
|
|
ADRB1
|
[NCBI]
|
1.81814e-05
|
|
|
CAMK2A
|
[NCBI]
|
1.81814e-05
|
|
|
PARK2
|
[NCBI]
|
1.81575e-05
|
|
|
DRPLA
|
[NCBI]
|
1.80823e-05
|
|
|
VDR
|
[NCBI]
|
1.776e-05
|
|
|
CSH1
|
[NCBI]
|
1.7524e-05
|
|
|
SCNN1B
|
[NCBI]
|
1.7524e-05
|
|
|
FGB
|
[NCBI]
|
1.7524e-05
|
|
|
MTR
|
[NCBI]
|
1.74287e-05
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
1.73284e-05
|
|
|
HCH
|
[NCBI]
|
1.73284e-05
|
|
|
C4A
|
[NCBI]
|
1.72422e-05
|
|
|
PFKM
|
[NCBI]
|
1.69079e-05
|
|
|
SURF1
|
[NCBI]
|
1.69079e-05
|
|
|
ADSL
|
[NCBI]
|
1.69079e-05
|
|
|
TCF3
|
[NCBI]
|
1.69079e-05
|
|
|
NETH
|
[NCBI]
|
1.68964e-05
|
|
|
hypouricemia, renal
|
[NCBI]
|
1.68964e-05
|
|
|
hyperostosis corticalis generalisata
|
[NCBI]
|
1.68964e-05
|
|
|
17-@beta hydroxysteroid dehydrogenase iii deficiency
|
[NCBI]
|
1.68964e-05
|
|
|
trifunctional protein deficiency
|
[NCBI]
|
1.68964e-05
|
|
|
alport syndrome, autosomal recessive
|
[NCBI]
|
1.68964e-05
|
|
|
USH1D
|
[NCBI]
|
1.68964e-05
|
|
|
renal tubular acidosis, distal, with progressive nerve deafness
|
[NCBI]
|
1.68964e-05
|
|
|
ATLD
|
[NCBI]
|
1.68964e-05
|
|
|
CDB1
|
[NCBI]
|
1.68964e-05
|
|
|
PCS
|
[NCBI]
|
1.68964e-05
|
|
|
situs inversus viscerum
|
[NCBI]
|
1.68964e-05
|
|
|
kindler syndrome
|
[NCBI]
|
1.68964e-05
|
|
|
argininemia
|
[NCBI]
|
1.68964e-05
|
|
|
BRIC1
|
[NCBI]
|
1.68964e-05
|
|
|
gaucher disease, perinatal lethal
|
[NCBI]
|
1.68964e-05
|
|
|
CTLN2
|
[NCBI]
|
1.68964e-05
|
|
|
PBT
|
[NCBI]
|
1.68964e-05
|
|
|
hepatitis b virus, susceptibility to
|
[NCBI]
|
1.68964e-05
|
|
|
glycogen storage disease ic
|
[NCBI]
|
1.68964e-05
|
|
|
keratitis-ichthyosis-deafness syndrome, autosomal dominant
|
[NCBI]
|
1.68964e-05
|
|
|
CTSC
|
[NCBI]
|
1.66037e-05
|
|
|
SJS1
|
[NCBI]
|
1.65362e-05
|
|
|
TBS
|
[NCBI]
|
1.65362e-05
|
|
|
mitochondrial complex i deficiency
|
[NCBI]
|
1.65362e-05
|
|
|
walker-warburg syndrome
|
[NCBI]
|
1.65362e-05
|
|
|
ALPS
|
[NCBI]
|
1.63423e-05
|
|
|
3-@beta-hydroxysteroid dehydrogenase, type ii, deficiency of
|
[NCBI]
|
1.63287e-05
|
|
|
NR4A2
|
[NCBI]
|
1.63287e-05
|
|
|
G6PT1
|
[NCBI]
|
1.63287e-05
|
|
|
PER2
|
[NCBI]
|
1.63287e-05
|
|
|
XRCC9
|
[NCBI]
|
1.63287e-05
|
|
|
HADHA
|
[NCBI]
|
1.63287e-05
|
|
|
TNFRSF13B
|
[NCBI]
|
1.63287e-05
|
|
|
GUCY2D
|
[NCBI]
|
1.63287e-05
|
|
|
FLT4
|
[NCBI]
|
1.63287e-05
|
|
|
FUT2
|
[NCBI]
|
1.63287e-05
|
|
|
PLG
|
[NCBI]
|
1.6007e-05
|
|
|
ADCYAP1
|
[NCBI]
|
1.59723e-05
|
|
|
GDNF
|
[NCBI]
|
1.58084e-05
|
|
|
CA2
|
[NCBI]
|
1.57826e-05
|
|
|
HAP1
|
[NCBI]
|
1.57826e-05
|
|
|
GALK1
|
[NCBI]
|
1.57826e-05
|
|
|
SFTPB
|
[NCBI]
|
1.57826e-05
|
|
|
CSF1
|
[NCBI]
|
1.57826e-05
|
|
|
FIH
|
[NCBI]
|
1.57787e-05
|
|
|
CLN3
|
[NCBI]
|
1.57787e-05
|
|
|
P2RX5
|
[NCBI]
|
1.56897e-05
|
|
|
RRM2B
|
[NCBI]
|
1.56897e-05
|
|
|
deleted in breast cancer 1
|
[NCBI]
|
1.56897e-05
|
|
|
SMAD6
|
[NCBI]
|
1.56897e-05
|
|
|
ALG9
|
[NCBI]
|
1.56897e-05
|
|
|
PHGDH
|
[NCBI]
|
1.56897e-05
|
|
|
MTIF2
|
[NCBI]
|
1.56897e-05
|
|
|
MMSDH
|
[NCBI]
|
1.56897e-05
|
|
|
SETD1A
|
[NCBI]
|
1.56897e-05
|
|
|
CHST5
|
[NCBI]
|
1.56897e-05
|
|
|
parathyroid hormone-responsive b1 gene
|
[NCBI]
|
1.56897e-05
|
|
|
MTL5
|
[NCBI]
|
1.56897e-05
|
|
|
actin-binding protein, 34-kd
|
[NCBI]
|
1.56897e-05
|
|
|
CC2D1A
|
[NCBI]
|
1.56897e-05
|
|
|
CAPN5
|
[NCBI]
|
1.56897e-05
|
|
|
E2F5
|
[NCBI]
|
1.56897e-05
|
|
|
TRRAP
|
[NCBI]
|
1.56897e-05
|
|
|
POMT2
|
[NCBI]
|
1.56897e-05
|
|
|
neurochondrin
|
[NCBI]
|
1.56897e-05
|
|
|
RCN1
|
[NCBI]
|
1.56897e-05
|
|
|
MTHFD1L
|
[NCBI]
|
1.56897e-05
|
|
|
KY
|
[NCBI]
|
1.56897e-05
|
|
|
DPYS
|
[NCBI]
|
1.56897e-05
|
|
|
caytaxin
|
[NCBI]
|
1.56897e-05
|
|
|
CHFR
|
[NCBI]
|
1.56897e-05
|
|
|
oncogene ovc
|
[NCBI]
|
1.56897e-05
|
|
|
SEZ6L
|
[NCBI]
|
1.56897e-05
|
|
|
SH3BP2
|
[NCBI]
|
1.56897e-05
|
|
|
PEX10
|
[NCBI]
|
1.56897e-05
|
|
|
ATP6V0E1
|
[NCBI]
|
1.56897e-05
|
|
|
EVER2
|
[NCBI]
|
1.56897e-05
|
|
|
SUCLA2
|
[NCBI]
|
1.56897e-05
|
|
|
ATP6V0A4
|
[NCBI]
|
1.56897e-05
|
|
|
DYM
|
[NCBI]
|
1.56897e-05
|
|
|
HYAL3
|
[NCBI]
|
1.56897e-05
|
|
|
GSTM5
|
[NCBI]
|
1.56897e-05
|
|
|
SAR1B
|
[NCBI]
|
1.56897e-05
|
|
|
HP
|
[NCBI]
|
1.54344e-05
|
|
|
SMAX1
|
[NCBI]
|
1.54267e-05
|
|
|
MAP1B
|
[NCBI]
|
1.54193e-05
|
|
|
COL1A2
|
[NCBI]
|
1.53054e-05
|
|
|
ATS
|
[NCBI]
|
1.5294e-05
|
|
|
ASMD
|
[NCBI]
|
1.5294e-05
|
|
|
HSS
|
[NCBI]
|
1.5294e-05
|
|
|
cirrhosis, familial
|
[NCBI]
|
1.5294e-05
|
|
|
DGI1
|
[NCBI]
|
1.5294e-05
|
|
|
myeloperoxidase deficiency
|
[NCBI]
|
1.5294e-05
|
|
|
marshall syndrome
|
[NCBI]
|
1.5294e-05
|
|
|
DFNA12
|
[NCBI]
|
1.5294e-05
|
|
|
GJB6
|
[NCBI]
|
1.52664e-05
|
|
|
DRD3
|
[NCBI]
|
1.52664e-05
|
|
|
PYGM
|
[NCBI]
|
1.52664e-05
|
|
|
ALS1
|
[NCBI]
|
1.51245e-05
|
|
|
CDG1A
|
[NCBI]
|
1.5054e-05
|
|
|
AGT
|
[NCBI]
|
1.48686e-05
|
|
|
PF4
|
[NCBI]
|
1.47949e-05
|
|
|
ERCC1
|
[NCBI]
|
1.47773e-05
|
|
|
PLOD1
|
[NCBI]
|
1.47773e-05
|
|
|
ADAMTS13
|
[NCBI]
|
1.47773e-05
|
|
|
MPZ
|
[NCBI]
|
1.47277e-05
|
|
|
GCK
|
[NCBI]
|
1.47277e-05
|
|
|
CVID
|
[NCBI]
|
1.46991e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
1.46935e-05
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
1.46537e-05
|
|
|
ABL1
|
[NCBI]
|
1.46028e-05
|
|
|
SRF
|
[NCBI]
|
1.43777e-05
|
|
|
aHUS
|
[NCBI]
|
1.43602e-05
|
|
|
MYH7
|
[NCBI]
|
1.43429e-05
|
|
|
CYP1B1
|
[NCBI]
|
1.43128e-05
|
|
|
RPE65
|
[NCBI]
|
1.43128e-05
|
|
|
CASP8
|
[NCBI]
|
1.43128e-05
|
|
|
CPE
|
[NCBI]
|
1.41742e-05
|
|
|
PMD
|
[NCBI]
|
1.41374e-05
|
|
|
DFNA6
|
[NCBI]
|
1.38747e-05
|
|
|
SMDP1
|
[NCBI]
|
1.38747e-05
|
|
|
LGMD2D
|
[NCBI]
|
1.38747e-05
|
|
|
SNDI
|
[NCBI]
|
1.38747e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
1.38747e-05
|
|
|
pycnodysostosis
|
[NCBI]
|
1.38747e-05
|
|
|
medulloblastoma
|
[NCBI]
|
1.38747e-05
|
|
|
CDH23
|
[NCBI]
|
1.38709e-05
|
|
|
LDHA
|
[NCBI]
|
1.38709e-05
|
|
|
MB
|
[NCBI]
|
1.37554e-05
|
|
|
BWS
|
[NCBI]
|
1.37392e-05
|
|
|
FIGN
|
[NCBI]
|
1.37329e-05
|
|
|
CNTNAP2
|
[NCBI]
|
1.37329e-05
|
|
|
ITGA7
|
[NCBI]
|
1.37329e-05
|
|
|
RNASEH1
|
[NCBI]
|
1.37329e-05
|
|
|
PTPRS
|
[NCBI]
|
1.37329e-05
|
|
|
IRX5
|
[NCBI]
|
1.37329e-05
|
|
|
TLR6
|
[NCBI]
|
1.37329e-05
|
|
|
SNAP29
|
[NCBI]
|
1.37329e-05
|
|
|
LIPH
|
[NCBI]
|
1.37329e-05
|
|
|
pejvakin
|
[NCBI]
|
1.37329e-05
|
|
|
RHOBTB2
|
[NCBI]
|
1.37329e-05
|
|
|
NKX3A
|
[NCBI]
|
1.37329e-05
|
|
|
HSD17B8
|
[NCBI]
|
1.37329e-05
|
|
|
SLC25A3
|
[NCBI]
|
1.37329e-05
|
|
|
PDSS1
|
[NCBI]
|
1.37329e-05
|
|
|
ZNF202
|
[NCBI]
|
1.37329e-05
|
|
|
EBF2
|
[NCBI]
|
1.37329e-05
|
|
|
BBS2
|
[NCBI]
|
1.37329e-05
|
|
|
SLC5A3
|
[NCBI]
|
1.37329e-05
|
|
|
SLC25A15
|
[NCBI]
|
1.37329e-05
|
|
|
EVER1
|
[NCBI]
|
1.37329e-05
|
|
|
TBX6
|
[NCBI]
|
1.37329e-05
|
|
|
CDH12
|
[NCBI]
|
1.37329e-05
|
|
|
GATA5
|
[NCBI]
|
1.37329e-05
|
|
|
HPS4
|
[NCBI]
|
1.37329e-05
|
|
|
CACNA2D2
|
[NCBI]
|
1.37329e-05
|
|
|
SCN7A
|
[NCBI]
|
1.37329e-05
|
|
|
SLC12A6
|
[NCBI]
|
1.37329e-05
|
|
|
SFRS7
|
[NCBI]
|
1.37329e-05
|
|
|
STRA6
|
[NCBI]
|
1.37329e-05
|
|
|
PAXIP1
|
[NCBI]
|
1.37329e-05
|
|
|
CLK2
|
[NCBI]
|
1.37329e-05
|
|
|
TRAF4
|
[NCBI]
|
1.37329e-05
|
|
|
NR2C1
|
[NCBI]
|
1.37329e-05
|
|
|
COIL
|
[NCBI]
|
1.37329e-05
|
|
|
ALDH7A1
|
[NCBI]
|
1.37329e-05
|
|
|
SC5DL
|
[NCBI]
|
1.37329e-05
|
|
|
ALOXE3
|
[NCBI]
|
1.37329e-05
|
|
|
FRAS1
|
[NCBI]
|
1.37329e-05
|
|
|
CTDSPL
|
[NCBI]
|
1.37329e-05
|
|
|
L2HGDH
|
[NCBI]
|
1.37329e-05
|
|
|
SLC12A1
|
[NCBI]
|
1.37329e-05
|
|
|
SOX18
|
[NCBI]
|
1.37329e-05
|
|
|
LRP1B
|
[NCBI]
|
1.37329e-05
|
|
|
ORC3L
|
[NCBI]
|
1.37329e-05
|
|
|
PON1
|
[NCBI]
|
1.37275e-05
|
|
|
growth hormone insensitivity syndrome
|
[NCBI]
|
1.36957e-05
|
|
|
BCHE
|
[NCBI]
|
1.36515e-05
|
|
|
PMP22
|
[NCBI]
|
1.35527e-05
|
|
|
TYR
|
[NCBI]
|
1.31342e-05
|
|
|
KCNQ1
|
[NCBI]
|
1.31269e-05
|
|
|
PAX2
|
[NCBI]
|
1.30475e-05
|
|
|
NRAS
|
[NCBI]
|
1.30475e-05
|
|
|
ACP5
|
[NCBI]
|
1.28373e-05
|
|
|
MFS
|
[NCBI]
|
1.2678e-05
|
|
|
GJA5
|
[NCBI]
|
1.2663e-05
|
|
|
NM
|
[NCBI]
|
1.26077e-05
|
|
|
CDGG1
|
[NCBI]
|
1.26077e-05
|
|
|
bartter syndrome, antenatal, type 2
|
[NCBI]
|
1.26077e-05
|
|
|
USH3
|
[NCBI]
|
1.26077e-05
|
|
|
denys-drash syndrome
|
[NCBI]
|
1.26077e-05
|
|
|
DSMA1
|
[NCBI]
|
1.26077e-05
|
|
|
adrenal hyperplasia, congenital, due to steroid 11-beta-hydroxylase deficiency
|
[NCBI]
|
1.26077e-05
|
|
|
CMT2A1
|
[NCBI]
|
1.26077e-05
|
|
|
cutis laxa, autosomal recessive, type ii
|
[NCBI]
|
1.26077e-05
|
|
|
cutis laxa, autosomal recessive, type i
|
[NCBI]
|
1.26077e-05
|
|
|
AEZ
|
[NCBI]
|
1.26077e-05
|
|
|
MUT
|
[NCBI]
|
1.22949e-05
|
|
|
GPX1
|
[NCBI]
|
1.22949e-05
|
|
|
VN1R1
|
[NCBI]
|
1.22944e-05
|
|
|
FOXE3
|
[NCBI]
|
1.22944e-05
|
|
|
MAP3K13
|
[NCBI]
|
1.22944e-05
|
|
|
ADRA2B
|
[NCBI]
|
1.22944e-05
|
|
|
NDUFV2
|
[NCBI]
|
1.22944e-05
|
|
|
OSTM1
|
[NCBI]
|
1.22944e-05
|
|
|
MYOG
|
[NCBI]
|
1.22944e-05
|
|
|
PPP1R13L
|
[NCBI]
|
1.22944e-05
|
|
|
HSPA6
|
[NCBI]
|
1.22944e-05
|
|
|
HTRA2
|
[NCBI]
|
1.22944e-05
|
|
|
MALL
|
[NCBI]
|
1.22944e-05
|
|
|
CDK5RAP2
|
[NCBI]
|
1.22944e-05
|
|
|
LECT1
|
[NCBI]
|
1.22944e-05
|
|
|
SP4
|
[NCBI]
|
1.22944e-05
|
|
|
RGR
|
[NCBI]
|
1.22944e-05
|
|
|
TGM5
|
[NCBI]
|
1.22944e-05
|
|
|
SV2A
|
[NCBI]
|
1.22944e-05
|
|
|
CUGBP1
|
[NCBI]
|
1.22944e-05
|
|
|
MSC
|
[NCBI]
|
1.22944e-05
|
|
|
NBEA
|
[NCBI]
|
1.22944e-05
|
|
|
TXN2
|
[NCBI]
|
1.22944e-05
|
|
|
DBC1
|
[NCBI]
|
1.22944e-05
|
|
|
B4GALNT2
|
[NCBI]
|
1.22944e-05
|
|
|
ESX1L
|
[NCBI]
|
1.22944e-05
|
|
|
CPLX2
|
[NCBI]
|
1.22944e-05
|
|
|
STRC
|
[NCBI]
|
1.22944e-05
|
|
|
CDH6
|
[NCBI]
|
1.22944e-05
|
|
|
MTHFD2
|
[NCBI]
|
1.22944e-05
|
|
|
NDUFV1
|
[NCBI]
|
1.22944e-05
|
|
|
COMMD1
|
[NCBI]
|
1.22944e-05
|
|
|
ENDOG
|
[NCBI]
|
1.22944e-05
|
|
|
CXXC1
|
[NCBI]
|
1.22944e-05
|
|
|
COQ2
|
[NCBI]
|
1.22944e-05
|
|
|
SLC7A8
|
[NCBI]
|
1.22944e-05
|
|
|
PUS1
|
[NCBI]
|
1.22944e-05
|
|
|
ABAT
|
[NCBI]
|
1.22944e-05
|
|
|
SENP2
|
[NCBI]
|
1.22944e-05
|
|
|
EOMES
|
[NCBI]
|
1.22944e-05
|
|
|
RBM5
|
[NCBI]
|
1.22944e-05
|
|
|
rad54, s. cerevisiae, homolog of, b
|
[NCBI]
|
1.22944e-05
|
|
|
EIF2AK4
|
[NCBI]
|
1.22944e-05
|
|
|
ESPL1
|
[NCBI]
|
1.22944e-05
|
|
|
ITGA6
|
[NCBI]
|
1.22944e-05
|
|
|
jtv1 gene
|
[NCBI]
|
1.22944e-05
|
|
|
MX1
|
[NCBI]
|
1.22944e-05
|
|
|
CUL7
|
[NCBI]
|
1.22944e-05
|
|
|
TRIM13
|
[NCBI]
|
1.22944e-05
|
|
|
FUT7
|
[NCBI]
|
1.22944e-05
|
|
|
HIPK1
|
[NCBI]
|
1.22944e-05
|
|
|
PEX3
|
[NCBI]
|
1.22944e-05
|
|
|
FBP1
|
[NCBI]
|
1.22944e-05
|
|
|
NF1
|
[NCBI]
|
1.22015e-05
|
|
|
ADA
|
[NCBI]
|
1.21527e-05
|
|
|
SPTB
|
[NCBI]
|
1.19419e-05
|
|
|
SMPD1
|
[NCBI]
|
1.19419e-05
|
|
|
ARSB
|
[NCBI]
|
1.19419e-05
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
1.18634e-05
|
|
|
EV
|
[NCBI]
|
1.18439e-05
|
|
|
LPG
|
[NCBI]
|
1.14695e-05
|
|
|
JME
|
[NCBI]
|
1.14695e-05
|
|
|
HFTC
|
[NCBI]
|
1.14695e-05
|
|
|
CDS
|
[NCBI]
|
1.14695e-05
|
|
|
ARMD4
|
[NCBI]
|
1.14695e-05
|
|
|
sitosterolemia
|
[NCBI]
|
1.14695e-05
|
|
|
SCZD9
|
[NCBI]
|
1.14695e-05
|
|
|
PNDM
|
[NCBI]
|
1.14695e-05
|
|
|
diabetes insipidus, nephrogenic, autosomal
|
[NCBI]
|
1.14695e-05
|
|
|
coenzyme q10 deficiency
|
[NCBI]
|
1.14695e-05
|
|
|
WGN1
|
[NCBI]
|
1.14695e-05
|
|
|
pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities
|
[NCBI]
|
1.14695e-05
|
|
|
SGD
|
[NCBI]
|
1.14695e-05
|
|
|
methionine adenosyltransferase deficiency
|
[NCBI]
|
1.14695e-05
|
|
|
kaposi sarcoma
|
[NCBI]
|
1.14695e-05
|
|
|
asplenia with cardiovascular anomalies
|
[NCBI]
|
1.14695e-05
|
|
|
alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis
|
[NCBI]
|
1.14695e-05
|
|
|
mucolipidosis iiia
|
[NCBI]
|
1.14695e-05
|
|
|
HSCR2
|
[NCBI]
|
1.14695e-05
|
|
|
BCNS
|
[NCBI]
|
1.14036e-05
|
|
|
MSH6
|
[NCBI]
|
1.12777e-05
|
|
|
GCDH
|
[NCBI]
|
1.12777e-05
|
|
|
E2F1
|
[NCBI]
|
1.12777e-05
|
|
|
PCD
|
[NCBI]
|
1.11627e-05
|
|
|
SLC2A10
|
[NCBI]
|
1.11613e-05
|
|
|
TRAK1
|
[NCBI]
|
1.11613e-05
|
|
|
MESP2
|
[NCBI]
|
1.11613e-05
|
|
|
HOXD12
|
[NCBI]
|
1.11613e-05
|
|
|
GNB5
|
[NCBI]
|
1.11613e-05
|
|
|
MYL3
|
[NCBI]
|
1.11613e-05
|
|
|
KCNK2
|
[NCBI]
|
1.11613e-05
|
|
|
SYT3
|
[NCBI]
|
1.11613e-05
|
|
|
SAI1
|
[NCBI]
|
1.11613e-05
|
|
|
MOCS1
|
[NCBI]
|
1.11613e-05
|
|
|
NPHP3
|
[NCBI]
|
1.11613e-05
|
|
|
PDHX
|
[NCBI]
|
1.11613e-05
|
|
|
precursor mrna-processing factor 3, s. cerevisiae, homolog of
|
[NCBI]
|
1.11613e-05
|
|
|
DACH1
|
[NCBI]
|
1.11613e-05
|
|
|
CES2
|
[NCBI]
|
1.11613e-05
|
|
|
PER3
|
[NCBI]
|
1.11613e-05
|
|
|
NTF5
|
[NCBI]
|
1.11613e-05
|
|
|
RBBP9
|
[NCBI]
|
1.11613e-05
|
|
|
KIR2DL2
|
[NCBI]
|
1.11613e-05
|
|
|
DDO
|
[NCBI]
|
1.11613e-05
|
|
|
PLA2G1B
|
[NCBI]
|
1.11613e-05
|
|
|
GNA13
|
[NCBI]
|
1.11613e-05
|
|
|
GJC2
|
[NCBI]
|
1.11613e-05
|
|
|
P2RX4
|
[NCBI]
|
1.11613e-05
|
|
|
ALOX12B
|
[NCBI]
|
1.11613e-05
|
|
|
HOXD11
|
[NCBI]
|
1.11613e-05
|
|
|
BBS1
|
[NCBI]
|
1.11613e-05
|
|
|
CSHL1
|
[NCBI]
|
1.11613e-05
|
|
|
ABCC8
|
[NCBI]
|
1.10076e-05
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
1.09646e-05
|
|
|
CAPN3
|
[NCBI]
|
1.09646e-05
|
|
|
MEFV
|
[NCBI]
|
1.09646e-05
|
|
|
DCN
|
[NCBI]
|
1.09646e-05
|
|
|
ACE
|
[NCBI]
|
1.08141e-05
|
|
|
TSC2
|
[NCBI]
|
1.0674e-05
|
|
|
oca2 gene
|
[NCBI]
|
1.06631e-05
|
|
|
apc gene
|
[NCBI]
|
1.05508e-05
|
|
|
MAG
|
[NCBI]
|
1.04651e-05
|
|
|
BHC
|
[NCBI]
|
1.04417e-05
|
|
|
leprosy, susceptibility to
|
[NCBI]
|
1.04417e-05
|
|
|
lymphedema-distichiasis syndrome
|
[NCBI]
|
1.04417e-05
|
|
|
PALS
|
[NCBI]
|
1.04417e-05
|
|
|
holocarboxylase synthetase deficiency
|
[NCBI]
|
1.04417e-05
|
|
|
CHNG1
|
[NCBI]
|
1.04417e-05
|
|
|
SOST
|
[NCBI]
|
1.04417e-05
|
|
|
DNMT3B
|
[NCBI]
|
1.03726e-05
|
|
|
CLCN1
|
[NCBI]
|
1.03726e-05
|
|
|
POU1F1
|
[NCBI]
|
1.03726e-05
|
|
|
ESPN
|
[NCBI]
|
1.02299e-05
|
|
|
SLC6A9
|
[NCBI]
|
1.02299e-05
|
|
|
CDKN2D
|
[NCBI]
|
1.02299e-05
|
|
|
TICAM1
|
[NCBI]
|
1.02299e-05
|
|
|
RNF2
|
[NCBI]
|
1.02299e-05
|
|
|
SPHK2
|
[NCBI]
|
1.02299e-05
|
|
|
FGD4
|
[NCBI]
|
1.02299e-05
|
|
|
NHLH1
|
[NCBI]
|
1.02299e-05
|
|
|
DLX2
|
[NCBI]
|
1.02299e-05
|
|
|
FBLN5
|
[NCBI]
|
1.02299e-05
|
|
|
ESCO2
|
[NCBI]
|
1.02299e-05
|
|
|
CLEC4A
|
[NCBI]
|
1.02299e-05
|
|
|
FUBP1
|
[NCBI]
|
1.02299e-05
|
|
|
CTNNA2
|
[NCBI]
|
1.02299e-05
|
|
|
WHRN
|
[NCBI]
|
1.02299e-05
|
|
|
ACTN4
|
[NCBI]
|
1.02299e-05
|
|
|
PHKG2
|
[NCBI]
|
1.02299e-05
|
|
|
PLCE1
|
[NCBI]
|
1.02299e-05
|
|
|
GNAT1
|
[NCBI]
|
1.02299e-05
|
|
|
GCLC
|
[NCBI]
|
1.02299e-05
|
|
|
NHLRC1
|
[NCBI]
|
1.02299e-05
|
|
|
FANCB
|
[NCBI]
|
1.02299e-05
|
|
|
PRB2
|
[NCBI]
|
1.02299e-05
|
|
|
PCK1
|
[NCBI]
|
1.02299e-05
|
|
|
GAB1
|
[NCBI]
|
1.02299e-05
|
|
|
HAGH
|
[NCBI]
|
1.02299e-05
|
|
|
VPS13A
|
[NCBI]
|
1.02299e-05
|
|
|
UNC5C
|
[NCBI]
|
1.02299e-05
|
|
|
B3GALNT1
|
[NCBI]
|
1.02299e-05
|
|
|
TAP2
|
[NCBI]
|
1.02299e-05
|
|
|
CKB
|
[NCBI]
|
1.02299e-05
|
|
|
NPHP4
|
[NCBI]
|
1.02299e-05
|
|
|
DNMT3L
|
[NCBI]
|
1.02299e-05
|
|
|
C1QB
|
[NCBI]
|
1.02299e-05
|
|
|
PAX6
|
[NCBI]
|
1.01446e-05
|
|
|
FMO3
|
[NCBI]
|
1.00923e-05
|
|
|
MLH1
|
[NCBI]
|
9.97449e-06
|
|
|
GIP
|
[NCBI]
|
9.87488e-06
|
|
|
GDF5
|
[NCBI]
|
9.82183e-06
|
|
|
TYRP1
|
[NCBI]
|
9.82183e-06
|
|
|
wilson disease
|
[NCBI]
|
9.64659e-06
|
|
|
ABCC6
|
[NCBI]
|
9.56052e-06
|
|
|
PTHR1
|
[NCBI]
|
9.56052e-06
|
|
|
PRPH2
|
[NCBI]
|
9.56052e-06
|
|
|
RP
|
[NCBI]
|
9.54279e-06
|
|
|
TTP
|
[NCBI]
|
9.50959e-06
|
|
|
CMDD
|
[NCBI]
|
9.50959e-06
|
|
|
GCE
|
[NCBI]
|
9.50959e-06
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
9.50959e-06
|
|
|
VED
|
[NCBI]
|
9.50959e-06
|
|
|
alexander disease
|
[NCBI]
|
9.50959e-06
|
|
|
SLC11A2
|
[NCBI]
|
9.48217e-06
|
|
|
TSHR
|
[NCBI]
|
9.48217e-06
|
|
|
CYP1A1
|
[NCBI]
|
9.47786e-06
|
|
|
ADAM9
|
[NCBI]
|
9.44188e-06
|
|
|
E2F4
|
[NCBI]
|
9.44188e-06
|
|
|
GJC1
|
[NCBI]
|
9.44188e-06
|
|
|
LAMB2
|
[NCBI]
|
9.44188e-06
|
|
|
COLQ
|
[NCBI]
|
9.44188e-06
|
|
|
PROX1
|
[NCBI]
|
9.44188e-06
|
|
|
SLC39A4
|
[NCBI]
|
9.44188e-06
|
|
|
ISL1
|
[NCBI]
|
9.44188e-06
|
|
|
SYT4
|
[NCBI]
|
9.44188e-06
|
|
|
CUL2
|
[NCBI]
|
9.44188e-06
|
|
|
DSC3
|
[NCBI]
|
9.44188e-06
|
|
|
USH3A
|
[NCBI]
|
9.44188e-06
|
|
|
PTGFR
|
[NCBI]
|
9.44188e-06
|
|
|
GNS
|
[NCBI]
|
9.44188e-06
|
|
|
RPL7A
|
[NCBI]
|
9.44188e-06
|
|
|
PIP5K1C
|
[NCBI]
|
9.44188e-06
|
|
|
SEPN1
|
[NCBI]
|
9.44188e-06
|
|
|
LGR8
|
[NCBI]
|
9.44188e-06
|
|
|
CRYBB1
|
[NCBI]
|
9.44188e-06
|
|
|
CHIT1
|
[NCBI]
|
9.44188e-06
|
|
|
SLC27A4
|
[NCBI]
|
9.44188e-06
|
|
|
CLDN14
|
[NCBI]
|
9.44188e-06
|
|
|
CENPJ
|
[NCBI]
|
9.44188e-06
|
|
|
BMPR1B
|
[NCBI]
|
9.44188e-06
|
|
|
GABRD
|
[NCBI]
|
9.44188e-06
|
|
|
NT5C3
|
[NCBI]
|
9.44188e-06
|
|
|
SLC7A7
|
[NCBI]
|
9.44188e-06
|
|
|
INHBB
|
[NCBI]
|
9.44188e-06
|
|
|
KCNJ8
|
[NCBI]
|
9.44188e-06
|
|
|
EED
|
[NCBI]
|
9.44188e-06
|
|
|
ROBO1
|
[NCBI]
|
9.44188e-06
|
|
|
KIF1B
|
[NCBI]
|
9.44188e-06
|
|
|
SDHA
|
[NCBI]
|
9.44188e-06
|
|
|
CNGA3
|
[NCBI]
|
9.44188e-06
|
|
|
GNAT2
|
[NCBI]
|
9.44188e-06
|
|
|
NFE2L1
|
[NCBI]
|
9.44188e-06
|
|
|
GTS
|
[NCBI]
|
9.43447e-06
|
|
|
IDUA
|
[NCBI]
|
9.32382e-06
|
|
|
ALDH2
|
[NCBI]
|
9.30791e-06
|
|
|
RAG1
|
[NCBI]
|
9.30791e-06
|
|
|
FGG
|
[NCBI]
|
9.30791e-06
|
|
|
CMT1B
|
[NCBI]
|
9.27375e-06
|
|
|
FANCC
|
[NCBI]
|
9.06355e-06
|
|
|
JAG1
|
[NCBI]
|
9.06355e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
8.86572e-06
|
|
|
NOD2
|
[NCBI]
|
8.82703e-06
|
|
|
PKLR
|
[NCBI]
|
8.82703e-06
|
|
|
PPT1
|
[NCBI]
|
8.82703e-06
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
8.82703e-06
|
|
|
glioma of brain, familial
|
[NCBI]
|
8.81628e-06
|
|
|
GCKR
|
[NCBI]
|
8.76106e-06
|
|
|
ABCG8
|
[NCBI]
|
8.76106e-06
|
|
|
PEPB
|
[NCBI]
|
8.76106e-06
|
|
|
CYP3A7
|
[NCBI]
|
8.76106e-06
|
|
|
SACS
|
[NCBI]
|
8.76106e-06
|
|
|
ADORA2A
|
[NCBI]
|
8.76106e-06
|
|
|
CD3D
|
[NCBI]
|
8.76106e-06
|
|
|
TBCE
|
[NCBI]
|
8.76106e-06
|
|
|
PITPN
|
[NCBI]
|
8.76106e-06
|
|
|
DYNC1H1
|
[NCBI]
|
8.76106e-06
|
|
|
CRLF1
|
[NCBI]
|
8.76106e-06
|
|
|
CHX10
|
[NCBI]
|
8.76106e-06
|
|
|
SCGB3A2
|
[NCBI]
|
8.76106e-06
|
|
|
CASP10
|
[NCBI]
|
8.76106e-06
|
|
|
MAF
|
[NCBI]
|
8.76106e-06
|
|
|
SEMA5A
|
[NCBI]
|
8.76106e-06
|
|
|
BCKDHB
|
[NCBI]
|
8.76106e-06
|
|
|
CHRD
|
[NCBI]
|
8.76106e-06
|
|
|
ST8SIA2
|
[NCBI]
|
8.76106e-06
|
|
|
MKKS
|
[NCBI]
|
8.76106e-06
|
|
|
HOXD3
|
[NCBI]
|
8.76106e-06
|
|
|
ERCC4
|
[NCBI]
|
8.76106e-06
|
|
|
NOTCH4
|
[NCBI]
|
8.76106e-06
|
|
|
hemojuvelin
|
[NCBI]
|
8.76106e-06
|
|
|
LMO7
|
[NCBI]
|
8.76106e-06
|
|
|
FBLN1
|
[NCBI]
|
8.76106e-06
|
|
|
HBQ1
|
[NCBI]
|
8.76106e-06
|
|
|
ACTN3
|
[NCBI]
|
8.76106e-06
|
|
|
GTF2IRD1
|
[NCBI]
|
8.76106e-06
|
|
|
CASQ2
|
[NCBI]
|
8.76106e-06
|
|
|
AIPL1
|
[NCBI]
|
8.76106e-06
|
|
|
HCF2
|
[NCBI]
|
8.76106e-06
|
|
|
GNAI2
|
[NCBI]
|
8.76106e-06
|
|
|
DAXX
|
[NCBI]
|
8.76106e-06
|
|
|
OPTB3
|
[NCBI]
|
8.66112e-06
|
|
|
diabetes-deafness syndrome, maternally transmitted
|
[NCBI]
|
8.66112e-06
|
|
|
HPC1
|
[NCBI]
|
8.66112e-06
|
|
|
DHRD
|
[NCBI]
|
8.66112e-06
|
|
|
thyroid hormonogenesis, genetic defect in, 2a
|
[NCBI]
|
8.66112e-06
|
|
|
pituitary dwarfism iii
|
[NCBI]
|
8.66112e-06
|
|
|
neuropathy, congenital hypomyelinating
|
[NCBI]
|
8.66112e-06
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
8.66112e-06
|
|
|
crigler-najjar syndrome
|
[NCBI]
|
8.66112e-06
|
|
|
TMAU
|
[NCBI]
|
8.66112e-06
|
|
|
MVA
|
[NCBI]
|
8.66112e-06
|
|
|
MS
|
[NCBI]
|
8.60816e-06
|
|
|
EDN1
|
[NCBI]
|
8.59794e-06
|
|
|
fucosidosis
|
[NCBI]
|
8.59794e-06
|
|
|
ASS
|
[NCBI]
|
8.57206e-06
|
|
|
SMS
|
[NCBI]
|
8.38525e-06
|
|
|
POMC
|
[NCBI]
|
8.37691e-06
|
|
|
GAA
|
[NCBI]
|
8.37594e-06
|
|
|
CEBPE
|
[NCBI]
|
8.16345e-06
|
|
|
LDB3
|
[NCBI]
|
8.16345e-06
|
|
|
HPD
|
[NCBI]
|
8.16345e-06
|
|
|
RP1
|
[NCBI]
|
8.16345e-06
|
|
|
IL9R
|
[NCBI]
|
8.16345e-06
|
|
|
MLPH
|
[NCBI]
|
8.16345e-06
|
|
|
CYP24A1
|
[NCBI]
|
8.16345e-06
|
|
|
IL2RB
|
[NCBI]
|
8.16345e-06
|
|
|
PHYH
|
[NCBI]
|
8.16345e-06
|
|
|
A4GALT
|
[NCBI]
|
8.16345e-06
|
|
|
TNFSF13
|
[NCBI]
|
8.16345e-06
|
|
|
SETX
|
[NCBI]
|
8.16345e-06
|
|
|
SLC4A4
|
[NCBI]
|
8.16345e-06
|
|
|
MYOCD
|
[NCBI]
|
8.16345e-06
|
|
|
CD19
|
[NCBI]
|
8.16345e-06
|
|
|
BBS4
|
[NCBI]
|
8.16345e-06
|
|
|
SCO2
|
[NCBI]
|
8.16345e-06
|
|
|
CNGB3
|
[NCBI]
|
8.16345e-06
|
|
|
SLC19A2
|
[NCBI]
|
8.16345e-06
|
|
|
TTC10
|
[NCBI]
|
8.16345e-06
|
|
|
Ss
|
[NCBI]
|
8.16345e-06
|
|
|
CYP2E
|
[NCBI]
|
8.16345e-06
|
|
|
SREBF2
|
[NCBI]
|
8.16345e-06
|
|
|
EYA4
|
[NCBI]
|
8.16345e-06
|
|
|
DSG4
|
[NCBI]
|
8.16345e-06
|
|
|
SHC1
|
[NCBI]
|
8.16345e-06
|
|
|
GRID2
|
[NCBI]
|
8.16345e-06
|
|
|
TACSTD2
|
[NCBI]
|
8.16345e-06
|
|
|
NCAM1
|
[NCBI]
|
8.16345e-06
|
|
|
GBE1
|
[NCBI]
|
8.16345e-06
|
|
|
SYT2
|
[NCBI]
|
8.16345e-06
|
|
|
CD3E
|
[NCBI]
|
8.16345e-06
|
|
|
TFR2
|
[NCBI]
|
8.1607e-06
|
|
|
maple syrup urine disease
|
[NCBI]
|
7.95506e-06
|
|
|
AN2
|
[NCBI]
|
7.95506e-06
|
|
|
camurati-engelmann disease
|
[NCBI]
|
7.88644e-06
|
|
|
factor xii deficiency
|
[NCBI]
|
7.88644e-06
|
|
|
glycogen storage disease iv
|
[NCBI]
|
7.88644e-06
|
|
|
GABEB
|
[NCBI]
|
7.88644e-06
|
|
|
glucose transport defect, blood-brain barrier
|
[NCBI]
|
7.88644e-06
|
|
|
SHEP2
|
[NCBI]
|
7.88644e-06
|
|
|
FGFR3
|
[NCBI]
|
7.81294e-06
|
|
|
HEXA
|
[NCBI]
|
7.7501e-06
|
|
|
UCP1
|
[NCBI]
|
7.71462e-06
|
|
|
HOXA10
|
[NCBI]
|
7.63232e-06
|
|
|
CYP27A1
|
[NCBI]
|
7.63232e-06
|
|
|
ZMPSTE24
|
[NCBI]
|
7.63232e-06
|
|
|
SLC17A5
|
[NCBI]
|
7.63232e-06
|
|
|
ITCH
|
[NCBI]
|
7.63232e-06
|
|
|
GYS1
|
[NCBI]
|
7.63232e-06
|
|
|
NODAL
|
[NCBI]
|
7.63232e-06
|
|
|
PRMT1
|
[NCBI]
|
7.63232e-06
|
|
|
RORC
|
[NCBI]
|
7.63232e-06
|
|
|
EDG1
|
[NCBI]
|
7.63232e-06
|
|
|
BARD1
|
[NCBI]
|
7.63232e-06
|
|
|
T
|
[NCBI]
|
7.63232e-06
|
|
|
GSS
|
[NCBI]
|
7.63232e-06
|
|
|
HOXA1
|
[NCBI]
|
7.63232e-06
|
|
|
NPPB
|
[NCBI]
|
7.63232e-06
|
|
|
AMN
|
[NCBI]
|
7.63232e-06
|
|
|
SEMA3B
|
[NCBI]
|
7.63232e-06
|
|
|
PRKAA2
|
[NCBI]
|
7.63232e-06
|
|
|
SGCB
|
[NCBI]
|
7.63232e-06
|
|
|
NAGS
|
[NCBI]
|
7.63232e-06
|
|
|
CFD
|
[NCBI]
|
7.63232e-06
|
|
|
HK2
|
[NCBI]
|
7.63232e-06
|
|
|
SGKL
|
[NCBI]
|
7.63232e-06
|
|
|
FGF18
|
[NCBI]
|
7.63232e-06
|
|
|
EPHA4
|
[NCBI]
|
7.63232e-06
|
|
|
MDH1
|
[NCBI]
|
7.63232e-06
|
|
|
HOXA13
|
[NCBI]
|
7.63232e-06
|
|
|
CD247
|
[NCBI]
|
7.63232e-06
|
|
|
PLEC1
|
[NCBI]
|
7.63232e-06
|
|
|
DGS
|
[NCBI]
|
7.59717e-06
|
|
|
tyrosinemia, type i
|
[NCBI]
|
7.55246e-06
|
|
|
MEN1
|
[NCBI]
|
7.36859e-06
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
7.36859e-06
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
7.36132e-06
|
|
|
CLN2
|
[NCBI]
|
7.17735e-06
|
|
|
GEFS+
|
[NCBI]
|
7.17735e-06
|
|
|
VWM
|
[NCBI]
|
7.17735e-06
|
|
|
pancreatic carcinoma
|
[NCBI]
|
7.17735e-06
|
|
|
ESCS
|
[NCBI]
|
7.17735e-06
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
7.17735e-06
|
|
|
ABCA1
|
[NCBI]
|
7.17556e-06
|
|
|
factor x deficiency
|
[NCBI]
|
7.17556e-06
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
7.17556e-06
|
|
|
ARPKD
|
[NCBI]
|
7.1607e-06
|
|
|
ADH3
|
[NCBI]
|
7.15553e-06
|
|
|
ERCC8
|
[NCBI]
|
7.15553e-06
|
|
|
GAD1
|
[NCBI]
|
7.15553e-06
|
|
|
ARG1
|
[NCBI]
|
7.15553e-06
|
|
|
MLC1
|
[NCBI]
|
7.15553e-06
|
|
|
PITX3
|
[NCBI]
|
7.15553e-06
|
|
|
SAG
|
[NCBI]
|
7.15553e-06
|
|
|
MCPH1
|
[NCBI]
|
7.15553e-06
|
|
|
TFAP2B
|
[NCBI]
|
7.15553e-06
|
|
|
CNGB1
|
[NCBI]
|
7.15553e-06
|
|
|
DAPK1
|
[NCBI]
|
7.15553e-06
|
|
|
KIR2DL1
|
[NCBI]
|
7.15553e-06
|
|
|
GLUL
|
[NCBI]
|
7.15553e-06
|
|
|
SOST
|
[NCBI]
|
7.15553e-06
|
|
|
COL4A4
|
[NCBI]
|
7.15553e-06
|
|
|
RYR3
|
[NCBI]
|
7.15553e-06
|
|
|
SOAT1
|
[NCBI]
|
7.15553e-06
|
|
|
SMARCA4
|
[NCBI]
|
7.15553e-06
|
|
|
ZNF9
|
[NCBI]
|
7.15553e-06
|
|
|
IRF5
|
[NCBI]
|
7.15553e-06
|
|
|
CMH
|
[NCBI]
|
7.08414e-06
|
|
|
COL7A1
|
[NCBI]
|
6.99497e-06
|
|
|
TFPI
|
[NCBI]
|
6.9661e-06
|
|
|
MSTN
|
[NCBI]
|
6.81934e-06
|
|
|
RCC1
|
[NCBI]
|
6.78696e-06
|
|
|
plasmin inhibitor deficiency
|
[NCBI]
|
6.72397e-06
|
|
|
MATN3
|
[NCBI]
|
6.72397e-06
|
|
|
SEMA3F
|
[NCBI]
|
6.72397e-06
|
|
|
F13B
|
[NCBI]
|
6.72397e-06
|
|
|
EIF2S1
|
[NCBI]
|
6.72397e-06
|
|
|
NPC2
|
[NCBI]
|
6.72397e-06
|
|
|
COL6A2
|
[NCBI]
|
6.72397e-06
|
|
|
SPINK5
|
[NCBI]
|
6.72397e-06
|
|
|
XBP1
|
[NCBI]
|
6.72397e-06
|
|
|
PAPSS2
|
[NCBI]
|
6.72397e-06
|
|
|
SGCD
|
[NCBI]
|
6.72397e-06
|
|
|
PRKAG2
|
[NCBI]
|
6.72397e-06
|
|
|
ZAP70
|
[NCBI]
|
6.72397e-06
|
|
|
CHRNB2
|
[NCBI]
|
6.72397e-06
|
|
|
ICOS
|
[NCBI]
|
6.72397e-06
|
|
|
EMX2
|
[NCBI]
|
6.72397e-06
|
|
|
SILV
|
[NCBI]
|
6.72397e-06
|
|
|
ERBB4
|
[NCBI]
|
6.72397e-06
|
|
|
GH1
|
[NCBI]
|
6.54653e-06
|
|
|
porphyria, congenital erythropoietic
|
[NCBI]
|
6.52693e-06
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
6.52693e-06
|
|
|
canavan disease
|
[NCBI]
|
6.52693e-06
|
|
|
refsum disease, infantile form
|
[NCBI]
|
6.52693e-06
|
|
|
PARK8
|
[NCBI]
|
6.52693e-06
|
|
|
PLOSL
|
[NCBI]
|
6.52693e-06
|
|
|
HEPOD
|
[NCBI]
|
6.52693e-06
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
6.52693e-06
|
|
|
RGS2
|
[NCBI]
|
6.33068e-06
|
|
|
CEP290
|
[NCBI]
|
6.33068e-06
|
|
|
FLNB
|
[NCBI]
|
6.33068e-06
|
|
|
FYN
|
[NCBI]
|
6.33068e-06
|
|
|
LDLRAP1
|
[NCBI]
|
6.33068e-06
|
|
|
GOT1
|
[NCBI]
|
6.33068e-06
|
|
|
MSR1
|
[NCBI]
|
6.33068e-06
|
|
|
alsin
|
[NCBI]
|
6.33068e-06
|
|
|
MTP
|
[NCBI]
|
6.33068e-06
|
|
|
MTHFD1
|
[NCBI]
|
6.33068e-06
|
|
|
CYP3A5
|
[NCBI]
|
6.33068e-06
|
|
|
ATP1A1
|
[NCBI]
|
6.33068e-06
|
|
|
BLMH
|
[NCBI]
|
6.33068e-06
|
|
|
SDHC
|
[NCBI]
|
6.33068e-06
|
|
|
MAT1A
|
[NCBI]
|
6.33068e-06
|
|
|
MBD2
|
[NCBI]
|
6.33068e-06
|
|
|
ATXN2
|
[NCBI]
|
6.33068e-06
|
|
|
NAGA
|
[NCBI]
|
6.33068e-06
|
|
|
KRT9
|
[NCBI]
|
6.33068e-06
|
|
|
FCGR2A
|
[NCBI]
|
6.33068e-06
|
|
|
ABCB4
|
[NCBI]
|
6.33068e-06
|
|
|
SCD
|
[NCBI]
|
6.3278e-06
|
|
|
CYP2D6
|
[NCBI]
|
6.3203e-06
|
|
|
TG
|
[NCBI]
|
6.17473e-06
|
|
|
GALT
|
[NCBI]
|
6.16265e-06
|
|
|
FXN
|
[NCBI]
|
6.16265e-06
|
|
|
SLS
|
[NCBI]
|
6.08342e-06
|
|
|
MAFD6
|
[NCBI]
|
6.06852e-06
|
|
|
OPMD
|
[NCBI]
|
6.05122e-06
|
|
|
ADHD
|
[NCBI]
|
6.05122e-06
|
|
|
ITGB2
|
[NCBI]
|
6.00909e-06
|
|
|
NDN
|
[NCBI]
|
5.97017e-06
|
|
|
CD14
|
[NCBI]
|
5.97017e-06
|
|
|
TECTA
|
[NCBI]
|
5.97017e-06
|
|
|
HIC1
|
[NCBI]
|
5.97017e-06
|
|
|
PLA2G7
|
[NCBI]
|
5.97017e-06
|
|
|
3-@hydroxy-3-methylglutaryl-coa lyase deficiency
|
[NCBI]
|
5.97017e-06
|
|
|
FSHB
|
[NCBI]
|
5.97017e-06
|
|
|
RNR1
|
[NCBI]
|
5.97017e-06
|
|
|
PRH1
|
[NCBI]
|
5.97017e-06
|
|
|
KRT10
|
[NCBI]
|
5.97017e-06
|
|
|
AHCY
|
[NCBI]
|
5.97017e-06
|
|
|
NOTCH3
|
[NCBI]
|
5.97017e-06
|
|
|
SMARCB1
|
[NCBI]
|
5.97017e-06
|
|
|
SLC5A1
|
[NCBI]
|
5.97017e-06
|
|
|
CGA
|
[NCBI]
|
5.97017e-06
|
|
|
CLDN1
|
[NCBI]
|
5.97017e-06
|
|
|
AGXT
|
[NCBI]
|
5.97017e-06
|
|
|
SALL1
|
[NCBI]
|
5.97017e-06
|
|
|
MTMR2
|
[NCBI]
|
5.97017e-06
|
|
|
HABP2
|
[NCBI]
|
5.97017e-06
|
|
|
PNMT
|
[NCBI]
|
5.94427e-06
|
|
|
EDMD2
|
[NCBI]
|
5.92931e-06
|
|
|
histidinemia
|
[NCBI]
|
5.92931e-06
|
|
|
SCA17
|
[NCBI]
|
5.92931e-06
|
|
|
KIT
|
[NCBI]
|
5.85946e-06
|
|
|
DBA
|
[NCBI]
|
5.65226e-06
|
|
|
POMT1
|
[NCBI]
|
5.63805e-06
|
|
|
AP3B1
|
[NCBI]
|
5.63805e-06
|
|
|
CNP
|
[NCBI]
|
5.63805e-06
|
|
|
TNFRSF11A
|
[NCBI]
|
5.63805e-06
|
|
|
GDAP1
|
[NCBI]
|
5.63805e-06
|
|
|
MMP13
|
[NCBI]
|
5.63805e-06
|
|
|
ENAM
|
[NCBI]
|
5.63805e-06
|
|
|
GGCX
|
[NCBI]
|
5.63805e-06
|
|
|
EPAS1
|
[NCBI]
|
5.63805e-06
|
|
|
CTNS
|
[NCBI]
|
5.63805e-06
|
|
|
RAB27A
|
[NCBI]
|
5.63805e-06
|
|
|
NTF3
|
[NCBI]
|
5.63805e-06
|
|
|
CRB1
|
[NCBI]
|
5.63805e-06
|
|
|
GALE
|
[NCBI]
|
5.63805e-06
|
|
|
SLC26A3
|
[NCBI]
|
5.63805e-06
|
|
|
PJS
|
[NCBI]
|
5.61666e-06
|
|
|
REN
|
[NCBI]
|
5.57146e-06
|
|
|
PSEN2
|
[NCBI]
|
5.57146e-06
|
|
|
krabbe disease
|
[NCBI]
|
5.55731e-06
|
|
|
mannosidosis, alpha b, lysosomal
|
[NCBI]
|
5.37946e-06
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
5.37946e-06
|
|
|
thrombocythemia, essential
|
[NCBI]
|
5.37946e-06
|
|
|
RTD
|
[NCBI]
|
5.37946e-06
|
|
|
sialuria, finnish type
|
[NCBI]
|
5.37946e-06
|
|
|
long-chain 3-hydroxyacyl-coa dehydrogenase deficiency
|
[NCBI]
|
5.37946e-06
|
|
|
ehlers-danlos syndrome, type i
|
[NCBI]
|
5.37946e-06
|
|
|
fraser syndrome
|
[NCBI]
|
5.37946e-06
|
|
|
epidermolysis bullosa with pyloric atresia
|
[NCBI]
|
5.37946e-06
|
|
|
megaloblastic anemia 1
|
[NCBI]
|
5.37946e-06
|
|
|
CNC1
|
[NCBI]
|
5.37946e-06
|
|
|
CDK2
|
[NCBI]
|
5.33191e-06
|
|
|
COL18A1
|
[NCBI]
|
5.33078e-06
|
|
|
ZEB2
|
[NCBI]
|
5.33078e-06
|
|
|
NPHS1
|
[NCBI]
|
5.33078e-06
|
|
|
FLG
|
[NCBI]
|
5.33078e-06
|
|
|
SLC26A2
|
[NCBI]
|
5.33078e-06
|
|
|
EIF2C2
|
[NCBI]
|
5.33078e-06
|
|
|
TRIM25
|
[NCBI]
|
5.33078e-06
|
|
|
LRAT
|
[NCBI]
|
5.33078e-06
|
|
|
CRYBB2
|
[NCBI]
|
5.33078e-06
|
|
|
PCSK1
|
[NCBI]
|
5.33078e-06
|
|
|
RAPSN
|
[NCBI]
|
5.33078e-06
|
|
|
HLA-DPA1
|
[NCBI]
|
5.33078e-06
|
|
|
SCARB1
|
[NCBI]
|
5.33078e-06
|
|
|
LAMA2
|
[NCBI]
|
5.33078e-06
|
|
|
CYBA
|
[NCBI]
|
5.33078e-06
|
|
|
CPS1
|
[NCBI]
|
5.33078e-06
|
|
|
FCGR3A
|
[NCBI]
|
5.33078e-06
|
|
|
FBN1
|
[NCBI]
|
5.32936e-06
|
|
|
TYMS
|
[NCBI]
|
5.30368e-06
|
|
|
PGR
|
[NCBI]
|
5.26845e-06
|
|
|
SCA1
|
[NCBI]
|
5.26194e-06
|
|
|
CMM
|
[NCBI]
|
5.24642e-06
|
|
|
SLC45A2
|
[NCBI]
|
5.04542e-06
|
|
|
CRX
|
[NCBI]
|
5.04542e-06
|
|
|
orotic aciduria i
|
[NCBI]
|
5.04542e-06
|
|
|
MYO6
|
[NCBI]
|
5.04542e-06
|
|
|
GNB3
|
[NCBI]
|
5.04542e-06
|
|
|
DNMT3A
|
[NCBI]
|
5.04542e-06
|
|
|
WNT1
|
[NCBI]
|
5.04542e-06
|
|
|
C7
|
[NCBI]
|
5.04542e-06
|
|
|
CYP11A1
|
[NCBI]
|
5.04542e-06
|
|
|
NSD1
|
[NCBI]
|
5.04542e-06
|
|
|
ITGAV
|
[NCBI]
|
5.04542e-06
|
|
|
PPARG
|
[NCBI]
|
4.88381e-06
|
|
|
MLC
|
[NCBI]
|
4.87302e-06
|
|
|
MADA
|
[NCBI]
|
4.87302e-06
|
|
|
USH2A
|
[NCBI]
|
4.87302e-06
|
|
|
NEFL
|
[NCBI]
|
4.77954e-06
|
|
|
C5
|
[NCBI]
|
4.77954e-06
|
|
|
TPM3
|
[NCBI]
|
4.77954e-06
|
|
|
FOXC1
|
[NCBI]
|
4.77954e-06
|
|
|
TSIX
|
[NCBI]
|
4.77954e-06
|
|
|
GLRA1
|
[NCBI]
|
4.77954e-06
|
|
|
TAL1
|
[NCBI]
|
4.77954e-06
|
|
|
EPB42
|
[NCBI]
|
4.77954e-06
|
|
|
SQSTM1
|
[NCBI]
|
4.77954e-06
|
|
|
ANGPT2
|
[NCBI]
|
4.77954e-06
|
|
|
GLDC
|
[NCBI]
|
4.77954e-06
|
|
|
SREBF1
|
[NCBI]
|
4.77954e-06
|
|
|
Ge
|
[NCBI]
|
4.77954e-06
|
|
|
JK
|
[NCBI]
|
4.77954e-06
|
|
|
WT1
|
[NCBI]
|
4.69345e-06
|
|
|
prostate cancer
|
[NCBI]
|
4.55706e-06
|
|
|
EIF4E
|
[NCBI]
|
4.55222e-06
|
|
|
IL9
|
[NCBI]
|
4.53107e-06
|
|
|
KCNJ2
|
[NCBI]
|
4.53107e-06
|
|
|
IRDN
|
[NCBI]
|
4.53107e-06
|
|
|
SPR
|
[NCBI]
|
4.53107e-06
|
|
|
PGM3
|
[NCBI]
|
4.53107e-06
|
|
|
CRHR1
|
[NCBI]
|
4.53107e-06
|
|
|
FGF3
|
[NCBI]
|
4.53107e-06
|
|
|
KCNE1
|
[NCBI]
|
4.53107e-06
|
|
|
PCCB
|
[NCBI]
|
4.53107e-06
|
|
|
OFC1
|
[NCBI]
|
4.47597e-06
|
|
|
TGFB1
|
[NCBI]
|
4.43807e-06
|
|
|
NOTCH1
|
[NCBI]
|
4.43807e-06
|
|
|
CD36
|
[NCBI]
|
4.43807e-06
|
|
|
biotinidase deficiency
|
[NCBI]
|
4.40622e-06
|
|
|
RMD
|
[NCBI]
|
4.40622e-06
|
|
|
alcohol dependence
|
[NCBI]
|
4.40622e-06
|
|
|
EFE
|
[NCBI]
|
4.40622e-06
|
|
|
osteoporosis
|
[NCBI]
|
4.40622e-06
|
|
|
AKR1B1
|
[NCBI]
|
4.36043e-06
|
|
|
GPT
|
[NCBI]
|
4.32658e-06
|
|
|
tay-sachs disease, ab variant
|
[NCBI]
|
4.29829e-06
|
|
|
RAG2
|
[NCBI]
|
4.29829e-06
|
|
|
NEU1
|
[NCBI]
|
4.29829e-06
|
|
|
SYT1
|
[NCBI]
|
4.29829e-06
|
|
|
FTH1
|
[NCBI]
|
4.29829e-06
|
|
|
EPB41
|
[NCBI]
|
4.29829e-06
|
|
|
DMBT1
|
[NCBI]
|
4.29829e-06
|
|
|
BMP1
|
[NCBI]
|
4.29829e-06
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
4.29829e-06
|
|
|
DBT
|
[NCBI]
|
4.29829e-06
|
|
|
NIDDM
|
[NCBI]
|
4.28802e-06
|
|
|
BCR
|
[NCBI]
|
4.19633e-06
|
|
|
SDC2
|
[NCBI]
|
4.15555e-06
|
|
|
APS1
|
[NCBI]
|
4.14655e-06
|
|
|
HAMP
|
[NCBI]
|
4.07968e-06
|
|
|
EPHB2
|
[NCBI]
|
4.07968e-06
|
|
|
PTGS1
|
[NCBI]
|
4.07968e-06
|
|
|
CUBN
|
[NCBI]
|
4.07968e-06
|
|
|
DSP
|
[NCBI]
|
4.07968e-06
|
|
|
NTN1
|
[NCBI]
|
4.07968e-06
|
|
|
RXRA
|
[NCBI]
|
4.07968e-06
|
|
|
PEX7
|
[NCBI]
|
4.07968e-06
|
|
|
TBX5
|
[NCBI]
|
4.07968e-06
|
|
|
SERPINA6
|
[NCBI]
|
4.03703e-06
|
|
|
CHH
|
[NCBI]
|
4.03012e-06
|
|
|
TD1
|
[NCBI]
|
4.03012e-06
|
|
|
PAX3
|
[NCBI]
|
4.00723e-06
|
|
|
thiourea tasting
|
[NCBI]
|
3.97575e-06
|
|
|
CFNS
|
[NCBI]
|
3.97575e-06
|
|
|
hyperekplexia, hereditary
|
[NCBI]
|
3.97575e-06
|
|
|
PDB
|
[NCBI]
|
3.97575e-06
|
|
|
ODDD
|
[NCBI]
|
3.97575e-06
|
|
|
OCRL
|
[NCBI]
|
3.97575e-06
|
|
|
central core disease of muscle
|
[NCBI]
|
3.97575e-06
|
|
|
PAX5
|
[NCBI]
|
3.87397e-06
|
|
|
PIK3CA
|
[NCBI]
|
3.87397e-06
|
|
|
DBH
|
[NCBI]
|
3.87397e-06
|
|
|
IL1RN
|
[NCBI]
|
3.87397e-06
|
|
|
MPL
|
[NCBI]
|
3.87397e-06
|
|
|
HLA-DQB1
|
[NCBI]
|
3.87397e-06
|
|
|
FOXC2
|
[NCBI]
|
3.87397e-06
|
|
|
MYB
|
[NCBI]
|
3.87397e-06
|
|
|
JUN
|
[NCBI]
|
3.87397e-06
|
|
|
F12
|
[NCBI]
|
3.87397e-06
|
|
|
CYP27B1
|
[NCBI]
|
3.87397e-06
|
|
|
VAMP2
|
[NCBI]
|
3.68003e-06
|
|
|
PLAT
|
[NCBI]
|
3.68003e-06
|
|
|
AACT
|
[NCBI]
|
3.68003e-06
|
|
|
NR3C2
|
[NCBI]
|
3.68003e-06
|
|
|
APTX
|
[NCBI]
|
3.68003e-06
|
|
|
GJB3
|
[NCBI]
|
3.68003e-06
|
|
|
CAPN10
|
[NCBI]
|
3.68003e-06
|
|
|
CA1
|
[NCBI]
|
3.68003e-06
|
|
|
FOS
|
[NCBI]
|
3.68003e-06
|
|
|
NKX2-1
|
[NCBI]
|
3.68003e-06
|
|
|
MJD
|
[NCBI]
|
3.63093e-06
|
|
|
HD
|
[NCBI]
|
3.62169e-06
|
|
|
BRCA2
|
[NCBI]
|
3.59238e-06
|
|
|
HNFJ
|
[NCBI]
|
3.57871e-06
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
3.57871e-06
|
|
|
UROS
|
[NCBI]
|
3.49688e-06
|
|
|
TGFBI
|
[NCBI]
|
3.49688e-06
|
|
|
CYP11B1
|
[NCBI]
|
3.49688e-06
|
|
|
ACOX1
|
[NCBI]
|
3.49688e-06
|
|
|
TLR2
|
[NCBI]
|
3.47794e-06
|
|
|
HBG1
|
[NCBI]
|
3.34192e-06
|
|
|
RYR1
|
[NCBI]
|
3.34192e-06
|
|
|
GZMB
|
[NCBI]
|
3.32365e-06
|
|
|
HK1
|
[NCBI]
|
3.32365e-06
|
|
|
CLOCK
|
[NCBI]
|
3.32365e-06
|
|
|
KLF6
|
[NCBI]
|
3.32365e-06
|
|
|
TGM1
|
[NCBI]
|
3.32365e-06
|
|
|
SOD1
|
[NCBI]
|
3.29361e-06
|
|
|
ILK
|
[NCBI]
|
3.24637e-06
|
|
|
JAK2
|
[NCBI]
|
3.24637e-06
|
|
|
KCNH2
|
[NCBI]
|
3.24637e-06
|
|
|
FMR1
|
[NCBI]
|
3.20818e-06
|
|
|
CD59
|
[NCBI]
|
3.15958e-06
|
|
|
LDHB
|
[NCBI]
|
3.15958e-06
|
|
|
KCNA1
|
[NCBI]
|
3.15958e-06
|
|
|
PMS2
|
[NCBI]
|
3.15958e-06
|
|
|
TP53
|
[NCBI]
|
3.12392e-06
|
|
|
CTSK
|
[NCBI]
|
3.00399e-06
|
|
|
TSG101
|
[NCBI]
|
3.00399e-06
|
|
|
CD4
|
[NCBI]
|
3.00399e-06
|
|
|
PTPN1
|
[NCBI]
|
3.00399e-06
|
|
|
MLP
|
[NCBI]
|
3.00399e-06
|
|
|
ATXN8OS
|
[NCBI]
|
3.00399e-06
|
|
|
IL4R
|
[NCBI]
|
3.00399e-06
|
|
|
PER1
|
[NCBI]
|
3.00399e-06
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
2.89564e-06
|
|
|
menkes disease
|
[NCBI]
|
2.89564e-06
|
|
|
usher syndrome, type i
|
[NCBI]
|
2.8749e-06
|
|
|
neural tube defects
|
[NCBI]
|
2.8749e-06
|
|
|
SLC17A7
|
[NCBI]
|
2.85628e-06
|
|
|
CES1
|
[NCBI]
|
2.85628e-06
|
|
|
PRG4
|
[NCBI]
|
2.85628e-06
|
|
|
PRKAR1A
|
[NCBI]
|
2.85628e-06
|
|
|
PPIB
|
[NCBI]
|
2.85628e-06
|
|
|
ITGA2B
|
[NCBI]
|
2.85628e-06
|
|
|
KL
|
[NCBI]
|
2.85628e-06
|
|
|
contractural arachnodactyly, congenital
|
[NCBI]
|
2.85628e-06
|
|
|
PTCH1
|
[NCBI]
|
2.85628e-06
|
|
|
FAAH
|
[NCBI]
|
2.79635e-06
|
|
|
PMCH
|
[NCBI]
|
2.75091e-06
|
|
|
LFNG
|
[NCBI]
|
2.7159e-06
|
|
|
TNFRSF10A
|
[NCBI]
|
2.7159e-06
|
|
|
IPF1
|
[NCBI]
|
2.7159e-06
|
|
|
NOG
|
[NCBI]
|
2.7159e-06
|
|
|
C1NH
|
[NCBI]
|
2.7159e-06
|
|
|
CD2AP
|
[NCBI]
|
2.7159e-06
|
|
|
DLG1
|
[NCBI]
|
2.7159e-06
|
|
|
APEX
|
[NCBI]
|
2.7159e-06
|
|
|
HMBS
|
[NCBI]
|
2.69029e-06
|
|
|
DISC1
|
[NCBI]
|
2.58236e-06
|
|
|
PROS1
|
[NCBI]
|
2.58236e-06
|
|
|
RP1
|
[NCBI]
|
2.5638e-06
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
2.5638e-06
|
|
|
TF
|
[NCBI]
|
2.56178e-06
|
|
|
COMT
|
[NCBI]
|
2.50203e-06
|
|
|
LRP1
|
[NCBI]
|
2.45958e-06
|
|
|
complement component 6 deficiency
|
[NCBI]
|
2.45522e-06
|
|
|
NCOA3
|
[NCBI]
|
2.45522e-06
|
|
|
CYP11B2
|
[NCBI]
|
2.45522e-06
|
|
|
CST3
|
[NCBI]
|
2.45522e-06
|
|
|
CAV3
|
[NCBI]
|
2.45522e-06
|
|
|
IFNB1
|
[NCBI]
|
2.45522e-06
|
|
|
STAR
|
[NCBI]
|
2.43105e-06
|
|
|
SLC6A3
|
[NCBI]
|
2.42365e-06
|
|
|
G6PD
|
[NCBI]
|
2.41331e-06
|
|
|
EPOR
|
[NCBI]
|
2.40067e-06
|
|
|
IGF1R
|
[NCBI]
|
2.33408e-06
|
|
|
ALDH3A2
|
[NCBI]
|
2.33408e-06
|
|
|
COL6A1
|
[NCBI]
|
2.33408e-06
|
|
|
ALPL
|
[NCBI]
|
2.33408e-06
|
|
|
IL1A
|
[NCBI]
|
2.33408e-06
|
|
|
GCH1
|
[NCBI]
|
2.33408e-06
|
|
|
NRCLP1
|
[NCBI]
|
2.27739e-06
|
|
|
homocysteinemia
|
[NCBI]
|
2.27739e-06
|
|
|
HLA-B
|
[NCBI]
|
2.21858e-06
|
|
|
TERC
|
[NCBI]
|
2.21858e-06
|
|
|
MN
|
[NCBI]
|
2.21858e-06
|
|
|
NS1
|
[NCBI]
|
2.20726e-06
|
|
|
HNF1A
|
[NCBI]
|
2.1585e-06
|
|
|
SRS
|
[NCBI]
|
2.14114e-06
|
|
|
TLR4
|
[NCBI]
|
2.13341e-06
|
|
|
GPI
|
[NCBI]
|
2.12987e-06
|
|
|
CFI
|
[NCBI]
|
2.10838e-06
|
|
|
SAA1
|
[NCBI]
|
2.10838e-06
|
|
|
PSORS1
|
[NCBI]
|
2.06603e-06
|
|
|
BRCA1
|
[NCBI]
|
2.05365e-06
|
|
|
ABCC2
|
[NCBI]
|
2.03759e-06
|
|
|
LGMD2C
|
[NCBI]
|
2.01403e-06
|
|
|
FPLD2
|
[NCBI]
|
2.01403e-06
|
|
|
PLTP
|
[NCBI]
|
2.00983e-06
|
|
|
ERCC5
|
[NCBI]
|
2.00319e-06
|
|
|
PEPD
|
[NCBI]
|
2.00319e-06
|
|
|
NBS1
|
[NCBI]
|
2.00319e-06
|
|
|
OPRM1
|
[NCBI]
|
1.97908e-06
|
|
|
EIG
|
[NCBI]
|
1.93306e-06
|
|
|
TNFSF13B
|
[NCBI]
|
1.90272e-06
|
|
|
FHIT
|
[NCBI]
|
1.90272e-06
|
|
|
STAT5B
|
[NCBI]
|
1.90272e-06
|
|
|
GHRL
|
[NCBI]
|
1.90272e-06
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
1.90248e-06
|
|
|
CNTF
|
[NCBI]
|
1.89945e-06
|
|
|
PHEX
|
[NCBI]
|
1.80672e-06
|
|
|
MDM2
|
[NCBI]
|
1.80672e-06
|
|
|
PAI1
|
[NCBI]
|
1.80672e-06
|
|
|
GATA1
|
[NCBI]
|
1.80672e-06
|
|
|
CCD
|
[NCBI]
|
1.79423e-06
|
|
|
glycogen storage disease i
|
[NCBI]
|
1.71495e-06
|
|
|
LTA
|
[NCBI]
|
1.71495e-06
|
|
|
CYP3A4
|
[NCBI]
|
1.71495e-06
|
|
|
APP
|
[NCBI]
|
1.69697e-06
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
1.66386e-06
|
|
|
breast cancer
|
[NCBI]
|
1.66386e-06
|
|
|
PEMT
|
[NCBI]
|
1.6272e-06
|
|
|
RUNX2
|
[NCBI]
|
1.6272e-06
|
|
|
ABO
|
[NCBI]
|
1.6272e-06
|
|
|
LGMD2A
|
[NCBI]
|
1.55065e-06
|
|
|
SPG3A
|
[NCBI]
|
1.55065e-06
|
|
|
glycogen storage disease vii
|
[NCBI]
|
1.55065e-06
|
|
|
AHO
|
[NCBI]
|
1.54724e-06
|
|
|
DSG1
|
[NCBI]
|
1.54326e-06
|
|
|
C4B
|
[NCBI]
|
1.54326e-06
|
|
|
lynch syndrome i
|
[NCBI]
|
1.5373e-06
|
|
|
SDS
|
[NCBI]
|
1.5373e-06
|
|
|
SCA2
|
[NCBI]
|
1.5373e-06
|
|
|
KITLG
|
[NCBI]
|
1.51013e-06
|
|
|
hemophilia a
|
[NCBI]
|
1.51013e-06
|
|
|
GNMT
|
[NCBI]
|
1.46296e-06
|
|
|
MYH11
|
[NCBI]
|
1.46296e-06
|
|
|
GUSB
|
[NCBI]
|
1.45962e-06
|
|
|
DNMT1
|
[NCBI]
|
1.45919e-06
|
|
|
PSEN1
|
[NCBI]
|
1.3895e-06
|
|
|
HIF1A
|
[NCBI]
|
1.38611e-06
|
|
|
H19
|
[NCBI]
|
1.38611e-06
|
|
|
MYOC
|
[NCBI]
|
1.36887e-06
|
|
|
CMD1A
|
[NCBI]
|
1.34805e-06
|
|
|
CTLA4
|
[NCBI]
|
1.31255e-06
|
|
|
SEMA3A
|
[NCBI]
|
1.31255e-06
|
|
|
HLA-DRA
|
[NCBI]
|
1.31255e-06
|
|
|
FGFR2
|
[NCBI]
|
1.3012e-06
|
|
|
IBD1
|
[NCBI]
|
1.29608e-06
|
|
|
DSTN
|
[NCBI]
|
1.24214e-06
|
|
|
BRAF
|
[NCBI]
|
1.24214e-06
|
|
|
SCN4A
|
[NCBI]
|
1.24214e-06
|
|
|
ADIPOQ
|
[NCBI]
|
1.24214e-06
|
|
|
MM
|
[NCBI]
|
1.16332e-06
|
|
|
OCA2
|
[NCBI]
|
1.16332e-06
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
1.16332e-06
|
|
|
CLL
|
[NCBI]
|
1.16332e-06
|
|
|
PCTT
|
[NCBI]
|
1.16332e-06
|
|
|
SLC2A4
|
[NCBI]
|
1.13047e-06
|
|
|
IAPP
|
[NCBI]
|
1.0976e-06
|
|
|
asthma, susceptibility to
|
[NCBI]
|
1.07147e-06
|
|
|
MAPK14
|
[NCBI]
|
1.04843e-06
|
|
|
FGF2
|
[NCBI]
|
1.02124e-06
|
|
|
malaria, susceptibility to
|
[NCBI]
|
9.95434e-07
|
|
|
GCPS
|
[NCBI]
|
9.95434e-07
|
|
|
MEB
|
[NCBI]
|
9.95434e-07
|
|
|
IFNG
|
[NCBI]
|
9.89289e-07
|
|
|
TNFRSF6
|
[NCBI]
|
9.89289e-07
|
|
|
ESR1
|
[NCBI]
|
9.37748e-07
|
|
|
CD47
|
[NCBI]
|
9.32681e-07
|
|
|
AMH
|
[NCBI]
|
9.04841e-07
|
|
|
CDK5
|
[NCBI]
|
8.91479e-07
|
|
|
AKT1
|
[NCBI]
|
8.78501e-07
|
|
|
AANAT
|
[NCBI]
|
8.78501e-07
|
|
|
NTRK1
|
[NCBI]
|
8.78501e-07
|
|
|
PRF1
|
[NCBI]
|
8.78501e-07
|
|
|
WAS
|
[NCBI]
|
8.78501e-07
|
|
|
MLL
|
[NCBI]
|
8.78501e-07
|
|
|
CD
|
[NCBI]
|
8.75735e-07
|
|
|
CMT1A
|
[NCBI]
|
8.64485e-07
|
|
|
LFS1
|
[NCBI]
|
8.43465e-07
|
|
|
COH1
|
[NCBI]
|
8.43465e-07
|
|
|
ATS
|
[NCBI]
|
8.43465e-07
|
|
|
neuraminidase deficiency
|
[NCBI]
|
8.43465e-07
|
|
|
AGER
|
[NCBI]
|
8.39569e-07
|
|
|
BGLAP
|
[NCBI]
|
8.39569e-07
|
|
|
PKD1
|
[NCBI]
|
8.38363e-07
|
|
|
CACNA1A
|
[NCBI]
|
8.26656e-07
|
|
|
TBG
|
[NCBI]
|
8.26656e-07
|
|
|
DSG3
|
[NCBI]
|
7.77054e-07
|
|
|
isoniazid inactivation
|
[NCBI]
|
7.77054e-07
|
|
|
RIPK1
|
[NCBI]
|
7.29612e-07
|
|
|
IGHG1
|
[NCBI]
|
7.29612e-07
|
|
|
SCN5A
|
[NCBI]
|
7.29612e-07
|
|
|
CCND1
|
[NCBI]
|
7.16809e-07
|
|
|
TPO
|
[NCBI]
|
7.11852e-07
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
7.06549e-07
|
|
|
HYPP
|
[NCBI]
|
7.06549e-07
|
|
|
PDS
|
[NCBI]
|
7.06549e-07
|
|
|
TBP
|
[NCBI]
|
6.9421e-07
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
6.76211e-07
|
|
|
RHO
|
[NCBI]
|
6.70973e-07
|
|
|
PROCR
|
[NCBI]
|
6.40891e-07
|
|
|
KDR
|
[NCBI]
|
6.25383e-07
|
|
|
SLC18A2
|
[NCBI]
|
5.99464e-07
|
|
|
INSL3
|
[NCBI]
|
5.99464e-07
|
|
|
TFRC
|
[NCBI]
|
5.99464e-07
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
5.89461e-07
|
|
|
DDC
|
[NCBI]
|
5.80999e-07
|
|
|
LBR
|
[NCBI]
|
5.59901e-07
|
|
|
A2M
|
[NCBI]
|
5.59901e-07
|
|
|
GJA1
|
[NCBI]
|
5.37894e-07
|
|
|
RET
|
[NCBI]
|
5.32088e-07
|
|
|
DRD2
|
[NCBI]
|
5.22139e-07
|
|
|
IGF2
|
[NCBI]
|
4.86116e-07
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
4.74765e-07
|
|
|
ALB
|
[NCBI]
|
4.42176e-07
|
|
|
OMP
|
[NCBI]
|
4.41352e-07
|
|
|
CDH1
|
[NCBI]
|
4.19058e-07
|
|
|
PGK1
|
[NCBI]
|
4.19058e-07
|
|
|
IGF1
|
[NCBI]
|
4.19058e-07
|
|
|
ASL
|
[NCBI]
|
4.19058e-07
|
|
|
SLC11A1
|
[NCBI]
|
4.19058e-07
|
|
|
WT1
|
[NCBI]
|
3.87916e-07
|
|
|
KLF1
|
[NCBI]
|
3.87916e-07
|
|
|
GSC
|
[NCBI]
|
3.87916e-07
|
|
|
IGER
|
[NCBI]
|
3.78489e-07
|
|
|
ESD
|
[NCBI]
|
3.78467e-07
|
|
|
SLC6A4
|
[NCBI]
|
3.6186e-07
|
|
|
MAPT
|
[NCBI]
|
3.42119e-07
|
|
|
CYP19A1
|
[NCBI]
|
3.30154e-07
|
|
|
MMP2
|
[NCBI]
|
3.30154e-07
|
|
|
IRS1
|
[NCBI]
|
3.03442e-07
|
|
|
RDT
|
[NCBI]
|
2.9554e-07
|
|
|
TCOF
|
[NCBI]
|
2.9554e-07
|
|
|
HAE
|
[NCBI]
|
2.9444e-07
|
|
|
UCP2
|
[NCBI]
|
2.90401e-07
|
|
|
GJB1
|
[NCBI]
|
2.90401e-07
|
|
|
SPARC
|
[NCBI]
|
2.78117e-07
|
|
|
JAK3
|
[NCBI]
|
2.78117e-07
|
|
|
LIPC
|
[NCBI]
|
2.54138e-07
|
|
|
CP
|
[NCBI]
|
2.3582e-07
|
|
|
GCCR
|
[NCBI]
|
2.31465e-07
|
|
|
CDC2
|
[NCBI]
|
2.31465e-07
|
|
|
GC
|
[NCBI]
|
2.27001e-07
|
|
|
RTS
|
[NCBI]
|
2.22034e-07
|
|
|
VMD
|
[NCBI]
|
2.22034e-07
|
|
|
JPS
|
[NCBI]
|
2.22034e-07
|
|
|
fabry disease
|
[NCBI]
|
2.20192e-07
|
|
|
COL1A1
|
[NCBI]
|
2.12102e-07
|
|
|
NR5A1
|
[NCBI]
|
2.1006e-07
|
|
|
CTNNB1
|
[NCBI]
|
2.1006e-07
|
|
|
CCL2
|
[NCBI]
|
1.89888e-07
|
|
|
MKS1
|
[NCBI]
|
1.82999e-07
|
|
|
LQT1
|
[NCBI]
|
1.82999e-07
|
|
|
AQP2
|
[NCBI]
|
1.70913e-07
|
|
|
MAOA
|
[NCBI]
|
1.57057e-07
|
|
|
IL10
|
[NCBI]
|
1.53102e-07
|
|
|
PCI
|
[NCBI]
|
1.44411e-07
|
|
|
DRD4
|
[NCBI]
|
1.36424e-07
|
|
|
PENK
|
[NCBI]
|
1.36424e-07
|
|
|
FSHR
|
[NCBI]
|
1.20847e-07
|
|
|
LOX
|
[NCBI]
|
1.20847e-07
|
|
|
NRG1
|
[NCBI]
|
1.20515e-07
|
|
|
IL6
|
[NCBI]
|
1.17042e-07
|
|
|
sotos syndrome
|
[NCBI]
|
1.10025e-07
|
|
|
SRC
|
[NCBI]
|
1.09281e-07
|
|
|
FFI
|
[NCBI]
|
1.05699e-07
|
|
|
INS
|
[NCBI]
|
1.03084e-07
|
|
|
CPB2
|
[NCBI]
|
8.82844e-08
|
|
|
SHH
|
[NCBI]
|
7.35261e-08
|
|
|
GNAS
|
[NCBI]
|
6.93108e-08
|
|
|
FGF8
|
[NCBI]
|
5.85005e-08
|
|
|
SOD2
|
[NCBI]
|
5.24708e-08
|
|
|
MTTL1
|
[NCBI]
|
4.89558e-08
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
3.85526e-08
|
|
|
NPS
|
[NCBI]
|
3.85526e-08
|
|
|
neuroblastoma
|
[NCBI]
|
3.85526e-08
|
|
|
PRLR
|
[NCBI]
|
3.77435e-08
|
|
|
PTGS2
|
[NCBI]
|
3.12413e-08
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
1.69344e-08
|
|
|
AQP1
|
[NCBI]
|
1.02184e-08
|
|
|
ABCG2
|
[NCBI]
|
7.75906e-09
|
|
|
PLN
|
[NCBI]
|
6.65954e-09
|
|
|
IHH
|
[NCBI]
|
5.15462e-09
|
|
|
HHT
|
[NCBI]
|
4.20448e-09
|
|
|
LCT
|
[NCBI]
|
3.87809e-09
|
|
|
UCP3
|
[NCBI]
|
1.85658e-09
|
|
|
HEMB
|
[NCBI]
|
3.71465e-10
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
1.85661e-10
|
|
|
AMC
|
[NCBI]
|
1.97302e-13
|
|
|
MHS1
|
[NCBI]
|
1.97302e-13
|
|
|
FCMD
|
[NCBI]
|
1.97302e-13
|
|
|
OCP
|
[NCBI]
|
1.97302e-13
|
|